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ABSTRACT
The overall aim of this thesis was to determine how natural killer (N) cells
regulate virus infections in vivo. Anti-viral mechanisms by which NK cells control murine
cytomegalovirus (MCMV) infection in the spleens and livers of adult C57BL/6 mice were
first studied, revealing different mechanisms of control in different organs. Three days
post-infection, MCMV titers in the spleens of perf orin-deficient (perforin 0/0) mice were
higher than in wild type controls, but no elevation of liver titers was found in perf orin 0/0
mice. NK cell depletion in MCMV -infected perf orin % mice resulted only in an increase
in liver viral titers but not in spleen titers. Depletion of IF- in adult C57BL/6 mice by
injections with mAbs to IF- resulted in an increase in viral titers in the liver but not in
the spleen. Analyses using IF-y-receptor-deficient (IF- 0/o mice, rendered chimeric
with C57BL/6 bone marrow cells, indicated that even though the donor spleen cells could
respond to IF-
y, 
the depletion ofNK cells in a recipient environment where the host cells
could not respond to IF- caused an increase in MCMV titers in the spleens but had little
effect in the liver. IF- has the ability to induce a variety of cells to produce nitric oxide
(NO), and administrating the nitric oxide synthase (NOS) inhibitor -monomethyl-
arginine (L-NMA) into MCMV-infected adult C57BL/6 mice resulted in MCMV titer
increases in the liver but not in the spleen. These data indicate that in adult C57BL/6 mice
there is a dichotomy in the mechanisms utilized by NK cells in the regulation ofMCMV in
different organs. In the spleen NK cells exert their effects in a perf orin-dependent manner
suggesting a cytotoxic mechanism, whereas in the liver the production of IF- by NK
cells may be a predominant mechanism in the regulation of MCMV synthesis. These
results may explain why the Cmv-r (Cmv- J-resistant) locus, which maps closely to genes
regulating NK cell cytotoxic function, confers an NK cell-dependent resistance to MCMV
infection in the spleen but not in the liver.
The ability of adoptively transferred cells to protect suckling mice ITom MCMV was
another model used to study the mechansms utilized by NK cells in the regulation ofMCMV.
Adoptive transfers of 129, C57BL/6 and perfori spleen cells or lymphokine-activated
kier (LAK) cells into 4 - 6 day old MCMV-infected C57BL/6 suckling mice signcantly
lowered the splenic MCMV titers in these mice compared to the inected controls. Adoptive
transfers ofC57BL/6 spleen cells into MCMV-inected 129 suckling mice also decreased the
amount of MCMV in the 129 suckling mice, but C57BL/6 spleen cells could not regulate
MCMV synthesis when adoptively transferred into 129/I- 0/0 suckling mice. These results
suggest that, in the sucklg mouse model, the regulation of MCMV by the adoptively
transferred NK cells is via an IF- dependent, perf orin-independent Cmv- independent
mechansm.
The Cmv- J gene locus resides within the NK gene complex, in close proximity to the
Ly49 NK cell receptor famy. Analyses were cared out to determne if any of the 4 known
Ly49 NK cell receptors (Ly49A, C, D and G2) played a role in the control ofMCMV synthesis
by NK cells. Studies comparg the expression of the different Ly49 NK cell subsets in the
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spleen and the peritoneal cavity revealed that there were diferences in the distribution of the
Ly49 receptors on NK1.I+ cells. Three days post-MCMV infection, the percentage ofNK1.I
Ly49+ NK cells in the spleen and the peritoneal cavity were different than in naive
controls. Within the splenic NK 1. 1 + population, increases in NK 1. 1 + -Ly49 A + and NK 1. 1 +
Ly49G2+ cells but decreases in NK1.I Ly49C+ and NK1.I Ly49D+ cells were observed.
These changes in the spleen were accompanied by a concomitant decrease in NK 1. 1 + -
Ly49A+ cells and increases in NK1.I Ly49C+, NK1.I Ly49D+ and NK1.I Ly49G2
cells within the NK1.1 + population in the peritoneal cavity. These data suggest that 3 days
post-MCMV infection, there may be movement ofNK cells between the different organs.
The role of Ly49 NK cell receptors in the regulation of MCMV was tested using adult
C57BL/6 mice depleted of single or multiple Ly49 NK cell subsets. These in vivo
depletions did not affect the abilty of the residual NK cells to regulate MCMV synthesis.
LAK cells sorted into the different Ly49 NK cell subsets and adoptively transferred into
C57BL/6 suckling mice lowered the splenic MCMV titers in these mice. Together, these
results indicate that even though there is a redistribution of the Ly49 NK cell subsets
during MCMV infection, the presence or absence of anyone of the 4 tested Ly49 NK cell
receptors does not affect the regulation of MCMV by NK cells. However, there remain a
possibility that one of the undefined Ly49 receptors or an untested NK cell receptor may
be important in the control ofMCMV.
Most of the cloned NK cell receptors have been shown to bind to MHC class I
molecules, and MHC class I antigens have been implicated as modulators of target cell
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sensitivity to NK cell-mediated lysis. The regulation of vis infections and the fate ofNK cells
and their natural targets was examed in J32-microglobulin-deficient mice (J32m (-/- )J, which
have defective MHC class I expression. Inecions with either the NK cell-sensitive MCMV or
the NK cell-resistant lymphocytic choriomeningitis virus (LCMV signcantly augmented NK
cell activity in either C57BL/6 or J32m (-/-) mice. Depletion ofNK cells in vivo with antiserum
to asialo GM markedly enhanced the synthesis ofMCMV but had no effect on the synthesis of
LCMV in either strai of mouse. Adoptively transferred J32m (-/ -) spleen cells lowered splenic
MCMV titers in C57BL/6 suckling mice, not unlike adoptively transferred C57BL/6
spleen cells. Analysis of naturally NK cell-sensitive thymocyte targets ITom these vis-inected
J32m (-/-) mice revealed no cell surface expression of class I MHC detectable by conformation-
dependent or -independent antibodies, but the virus inections enhanced class I expression on
thymocytes ITom C57BL/6 mice. The sensitivity of C57BL/6 thymocytes to NK cell-mediated
lysis was markedly reduced afer in vivo poly inosinc:cytidylic (poly I:C) treatment or vial
inection; in contrast, the sensitivity of the J32m (-/-) thymocytes was signficantly less afected
by poly I:C or vial infection. These data indicate that the normal expression of MHC class I
antigens on NK cells or their targets is not required for the anti-viral functions of NK cells
agaist an NK-sensitive virus (MCMV nor do they protect an NK-resistant virus (LCMV
ITom the anti-viral activity ofNK cells.
Together, the data presented in this thesis help to further our understanding of the
mechansms utilized by NK cells in the control ofMCMV in both adult and suckling mice, and
also help clar the roles played by Ly49 NK cell receptors and MHC class I molecules in the
regulation ofMCMV.
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CHAPTER I
INTRODUCTION
The natural immune system consists of pre-existing or rapidly inducible effector
components as a first line of defense against pathogens to which the host has not
previously been exposed. Such a system is necessary, as the B and T cell-specific
responses to any pathogen require the selective expansion of high affnity antigen-specific
clones which take several days to develop. An unimpeded replication of a virus producing
progeny per cell could potentially infect all of the cells in the host after only 3 - 4
replication cycles. Without the natural immune system holding infections in check
pathogens could overwhelm the host before the T and B cell responses become effective.
In the mid 1970s, experiments studying cell-mediated immune responses to tumor
cells found that tumorigenic cells induced by Moloney leukemia virus or other retroviruses
could be lysed by leukocytes from unimmunized mice (Herberman et aI. , 1975; Kiessling
et aI. , 1975b). These effector cells represented a new kind of cytotoxic lymphoid cell and
were named as ' natural killer' (N) cells by Kiessling et al. (I975a). NK cells have a large
granular lymphocyte morphology (Monten et aI. , 1979) with their granules containing the
membrane pore-forming molecule, perf orin, and a group of serine proteases known as
granzmes (O'Shea and Ortaldo, 1992). These cells are bone-marrow derived (Haller and
Wigzell, 1977; Welsh, 1978), do not express the T cell receptor/CD3 complex or
immunoglobulins on their cell surfaces and do not rearrange their Band T cell antigen
receptor genes (Lanier et aI. , 1986; Biron et aI. , 1987). NK cells express receptors for the
Fe portion ofIgG (Herberman et aI. , 1977) and activated NK cells also express the T cell-
specific antigen, Thy 1 (Herberman et aI. , 1978). NK cells can be further distinguished
ITom other lymphoid cells by the expression ofasialo (aGM (Kasai et aI. , 1980) and
NK1.1 (Glimcher et aI., 1977) in mice, and CD56 (Lanier et aI., 1989) in humans. In
recent years, NK cells have been shown to express a variety of NK cell-specific receptors
encoded by genes found within the distal portion of mouse chromosome 6 and on human
chromosome 12p13. , in a region now known as the NK gene complex (Yokoyama, 1993;
Yokoyama, 1995a). Many of these NK cell receptors have MHC class I molecules as their
ligands (Gumperz and Parham, 1995; Raulet and Held, 1995; Colonna, 1996). NK cells
can secrete a number of cytokines, including interferon gamma (IF-
y), 
tumor necrosis
factor alpha (TN-a), granulocyte/macrophage colony stimulating factors (gm-cst) and
interleukin 1 (IL- I) (Trinchieri, 1989).
NK CELLS AN VIRUS INECTIONS
NK cells, which provide an early host response to viral, parasitic and bacterial
infections, are important components of the natural immune system. NK cells have now
been shown to provide resistance to some of these infections, as well as playing roles in
tumor surveilance and in the regulation of hematopoiesis (Storkus and Dawson, 1991;
Welsh and Vargas-Cortes, 1992; Bellone et aI. , 1993; Scott and Trinchieri, 1995). The 
vivo role of NK cells is most definitively shown by the regulation of murine
cytomegalovirus (MCMV) infection in mice. Genetic resistance of mice to MCMV maps
to a single gene within the NK gene complex (Scalzo et aI. , 1990; Scalzo et aI. , 1992).
Intraperitoneally (i.p. inoculated adult C57BL/6 mice depleted of NK cells with antisera
to aGM or with mAbs to NK 1. 1 have enhanced virus replication in the spleen, lung, and
liver (Bukowski et aI. , 1984; Welsh et aI. , 1991; Welsh et aI., 1994). Suckling mice are
very sensitive to MCMV until the third week of life, at which time the NK cell response
develops to maturity (Boos and Wheelock, 1971; Kiessling et aI., 1975a). Adoptive
transfer experiments using adult splenocyte populations or purified culture-derived NK
cells showed that NK cells protected suckling mice from MCMV (Bukowski et aI. , 1985).
NK cells were also shown to inhibit MCMV replication in mice with severe combined
immunodeficiency (SCID), demonstrating the function of these cells in an environment
devoid of T and B cells (Welsh et aI. , 1991; Welsh et aI. , 1994). However, NK cells in
SCID mice were incapable of completely eradicating MCMV, even at limiting dilutions of
the virus, indicating that T and/or B cells were ultimately necessary for clearance
(Brubaker, 1993). This is consistent with the concept that NK cells inhibit the spread of
infection, allowing time for specific immune responses to develop. In humans, the
importance ofNK cells was highlighted in our institution by a patient who had a complete
and selective NK cell immunodeficiency; this patient had unusually severe cases of human
cytomegalovirus (HCMV) infection and other herpes virus infections (Biron et aI. , 1989).
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How NK cells control MCMV and other viral infections in vivo has until recently
been a poorly understood phenomenon. Potential mechanisms would include the secretion
of anti-viral cytokines, such as IF- and TN-a., or alternatively, by the direct lysis of
virus-infected cells prior to the release of infectious virus progeny.
ACTIVATION OF NK CELLS DURING VIRUS INFECTIONS
When a virus infects a host, virus-infected cells are stimulated to produce IF-a.
and IF-J3, which wil induce the NK cells to proliferate and increase their cytotoxic
potential (Welsh, 1978; Biron and Welsh, 1982; Biron et aI. , 1984). In mice, the levels of
NK cell activation and blastogenesis parallel the IFN-alpha/eta (IF-a.J3) levels (Welsh
1978; Biron and Welsh, 1982), and direct injections of purified IF-J3 into mice induce
NK cell activation and proliferation (Biron et aI. , 1984). Mice treated with antibodies to
IF-a.J3 (Gidlund et aI. , 1978) or mice whose IF-a.J3 receptors have been inactivated by
genetic recombination (Muller et aI., 1994) generate a poor NK cell response to viral
infections (Biron, 1994). These activated NK cells respond to chemotactic factors and
migrate into areas of virus-infected tissue, such as the liver (McIntyre and Welsh, 1986;
Natuk and Welsh, 1987b; Natuk et aI. , 1989), where they are presumed to mediate their
anti-viral activities.
NK cells from virus-infected C57BL/6 mice have both high cytolytic activity and
the potential to produce anti-viral cytokines. They express transcripts for IF-
y, 
but the
translation of these transcripts into the IF- protein is dependent on additional factors.
Orange and Biron studied the differences in the cytokine responses in mice infected with
the NK-sensitive virus, MCMV, and in mice infected with lymphocytic choriomeningitis
virus (LCMV), which is very resistant to NK cells (Orange and Biron, 1996a; Orange and
Biron, 1 996b). Both infections induced Type I IFs, the cytolytic activation ofNK cells
and the expression of IF- mRA in NK cells. However, only in the MCMV infection
did the NK cells synthesize and secrete the IFN-y protein. The IF- production during
MCMV infection was linked to the fact that MCMV but not LCMV was a good inducer
ofIL- I2 in vivo (Orange and Biron, 1996a). IL- I2 is a pleiotropic cytokine produced by
macrophages and was shown in these studies to be required for the production of IF-
by NK cells early in the infection. Antibodies to IFN-y or IL-I2 did not affect NK cell
cytolytic activity, a result consistent with the concept that IF-alJ3 rather than IF-
activates NK cells at the early stages of infection (Orange et aI. , 1995).
Another cytokine that plays a role in the activation of NK cells is TN-a.. Data
generated using anti-TN-a-treated, MCMV-infected normal mice suggest that TN-a.
can synergize with IL- I2 to induce the production of IF- by NK cells (Orange and
Biron, 1996b). TN-a. can also inhibit the effects of IF-alJ3 on NK cells by negatively
infuencing NK cell blastogenesis and the induction of NK cell cytotoxicity (Orange and
Biron, 1996b).
ANI-VIR FuCTIONS OF NK CELL-PRODUCED CYTOKIS
A suggestion that NK cell-produced cytokines are important in controllng virus
infections came initially ITom studies using athymic nude mice infected with a vaccinia
virus (VV)-IL- recombiriant (Karupiah et aI., 1990). IL- is a strong activator
(Kuribayashi et aI. , 1981) as well as a chemotactic factor (Natuk and Welsh, 1987a) for
NK cells. This cytokine also has the ability to induce NK cells to produce IF- (Young
and Ortaldo, 1987). Administration of either anti-IFN-y Abs or anti-aGM antiserum into
the VV-IL-2 recombinant-infected nude mice exacerbated the infection, suggesting that
the production of IF- by the NK cells in the nude mice was controllng the infection
(Karupiah et aI. , 1990). A role for NK cell-produced IF- in an unmodified system has
since been established with MCMV (Orange et aI. , 1995). Depletion of IF- or IL-
with mAbs increased the incidence of MCMV -induced hepatitis and virus replication in the
liver (Orange et aI. , 1995; Orange and Biron, 1996a; Tay and Welsh, 1997).
The anti-viral functions of IF- have been studied extensively, with the results
indicating that the cytokine can impair various stages of viral replication, including viral
penetration and uncoating, transcription, translation and assembly of progeny viruses
(Vilcek and Sen, 1995). In the inhibition of positive stranded RNA viruses, Type I and
Type II interferons can induce the expression of an enzme called oligoadenylate
synthetase. Oligoadenylate synthetase is thought to be activated by the protein-free, naked
replicative intermediates of positive stranded RNA viruses to synthesize a family of
oligonucleotides, collectively known as 2 0ligo-A. 2 5 Oligo-A in turn wil activate a
cytoplasmic ribonuclease called RNase L, which wil cleave the viral RNA (Vilcek and
Sen, 1995). During virus infections, a dsRNA-dependent protein kinase PKR is also
induced by IFs. PKR is activated by the viral dsRNA to autophosphorylate and also to
phosphorylate the a subunit of the translation initiation factor eIF-2. Phosphorylated eIF-
cannot be used again in the translation process, thus effectively inhibiting the cellular
processes of the invading viruses in the cell (Vilcek and Sen, 1995). Another way IF-
can exert its anti-viral effects is by inducing the expression of the gene for inducible nitric
oxide synthase (iNOS) in cells such as macro phages, Kupffer cells and hepatocytes
(Nathan, 1992). NOS in turn catalyzes the production of a ITee radical gas, nitric oxide
(NO), ITom the guanidino nitrogen of L-arginine. NO production by NOS has been shown
both in vivo and in vitro to inhibit the replication of VV, ectromelia virus, and herpes
simplex virus type 1 (HSV- I) (Karupiah et aI. , 1993a; Harrs et aI. , 1995). Although the
molecular basis of NO action in the inhibition of virus replication is not known, NO
production has been shown in vitro to inhibit VV replication by blocking the replication of
viral DNA and late protein synthesis, but this molecule has no effect on the expression of
early VV proteins (Harris et aI. , 1995; Melkova and Esteban, 1995).
Another anti-viral cytokine that NK cells can secrete to control viral infections is
TN-a. An early report provided some evidence that TN-a and lymphotoxin produced
by cloned human NK cell lines can have anti-viral cytotoxicity and that human
recombinant TN-a. can selectively induce the lysis of vesicular stomatitis virus-, HCMV-
Theiler s murine encephalomyelitis virus-, and HSV- infected cells (Paya et aI. , 1988). 
vivo CD4+ T cell-dependent TN-a. production has been shown to participate in the
inhbition of MCMV replication (pavic et aI. , 1993), and in vitro this cytokine can
synergize with IF- to inhibit MCMV late protein production (Lucin et aI. , 1994). The
role of NK cell-produced TN -a. in the regulation of MCMV is not clear, as E26 mice
which do not have any T or NK cells, produce normal levels of TN-a. 2 to 3 days after
MCMV infection (Orange and Biron, 1996b). This means that NK cells are not a primary
or required source for the production of TN-a., which can be made at high levels by
macrophages and other cell types. Nevertheless, it is possible the NK cell-produced TN-
a. feeds back onto its own regulatory pathway and synergizes with IL- I2 to stimulate the
production of more IF-
ROLE OF NK CELL CYTOTOXICITY IN TH REGULATION OF VIRUS INECTIONS
In the cytoplasm of activated cytotoxic T lymphocytes (CTL) and NK cells are
azrophilic granules that contain the pore forming molecule perforin (Henkart et aI. , 1986;
Podack and Konigsberg, 1984). Perforin is structurally similar to the C9 component of
complement (Tschopp et aI., 1986; Young et aI., 1986a). When an NK cell comes in
contact with its target cell , microtubule and cytoskeleton reorganization within the NK cell
allows the cell to position its granules near the area of contact (Kupfer et aI. , 1983). In the
presence of Ca , the contents of the granules are released into the intracellular space.
Monomers of perf orin then bind to the target cell membrane and aggregate to form
polymers of perf orin known as polyperforin, which creates holes or ' punctures' in the
target cell membrane (Henkart et aI., 1984; Young et aI., 1986b). These polyperforin
channels disrupt the resting membrane potential of the target cell and allow the
indiscriminate exchange of water and cytoplasmic contents, ultimately leading to the lysis
of the target cell. The only evidence prior to the work presented in this thesis that suggest
a cytotoxic mechanism may be involved in the control ofMCMV comes from studies with
beige mice. Beige mice, whose NK cells are deficient in cytotoxic function, control
MCMV infection poorly (Shellam et aI., 1981; Bukowski et aI. , 1984). However, the
beige mutation confers a lysosomal defect affecting many types of leukocytes, and it is
possible that these other defects may infuence the ability of the beige mouse to control the
infection. NK cells have also been shown in vitro to be able to kil via Fas/Fas ligand
interaction, but the role ofFas in the ability ofNK cells to control virus infections has not
been tested (Murphy et aI. , 1995).
CMV- J AN TH GENETIC RESISTANCE OF MICE TO MCMV
Scalzo et al have shown that there is a non-MHC linked resistance gene to MCMV
that maps very closely to the NKJ. J and the Ly49 loci within the NK gene complex
(Scalzo et aI. , 1990; Scalzo et aI. , 1992; Scalzo et aI. , 1995b). The gene Cmv- confers
resistance to MCMV in the spleen but not in the liver (Scalzo et aI. , 1990). The effects of
Cmv- are mediated through NK1.1 + cells, and mice that have the gene (Cmv- l') have
lower splenic MCMV titers than strains of mice that do not have the gene (Cmv- I
(Scalzo et aI. , 1992). However, the viral titers in the livers of the different strains of mice
are similar. Since Cmv- is found within the NK locus, it is possible that the gene may be
differentially expressed in the various subsets of NK cells and that different subsets of NK
cells control MCMV in different organs. Alternatively, NK cells may utilize Cmv-
dependent mechanism to control MCMV in the spleen but another mechanism to control
the virus in the liver. Cmv- in the context ofNK cell receptors wil be discussed further 
the next section.
NK CELL RECEPTORS AN VIRUS INFECTIONS
The mapping of the Cmv- 1 locus within the NK gene complex raises the
possibility that the NK cell receptor molecules may interact with virus-infected targets. In
both the human and mouse systems, most of the cloned NK cell receptors interact with
MHC class I molecules and such an interaction can be either ' activatory' or inhibitory. In
the mouse most of the NK cell receptors cloned to date share a common feature: dimeric
type II transmembrane proteins whose extracellular domains have structural features 
calcium-dependent (C-type) lectins (Yokoyama, 1993; Brown et ai, 1997; Ryan and
Seaman, 1997). In humans, two classes ofNK cell receptors have been cloned. One group
of receptor complex is composed of Type II proteins with a C-type lectin domain, not
unlike the mouse NK cell receptors, and the second group belong to the Ig superfamily,
with 2 or 3 Ig-like domains in their extracellular portion (Moretta et ai, 1997; Ryan and
Seaman, 1997). Recently, there is a report that mouse NK cells may also express NK cell
receptors belonging to the Ig superfamily, but this has yet to be confirmed by other
investigators (Wang et aI. , 1997).
Different NK cell receptors have been shown to inhibit or activate NK cell
function, and within the same NK cell receptor family, different members can have
opposing functions (Mason et aI. , 1996; Raziuddin et aI. , 1996; Yu et aI. , 1996; Moretta et
aI. , 1997). This suggests that the molecular pathways by which NK cells are activated and
the inhbitory signals sent to prevent such an activation are different. In humans, two NK
cell receptors of the same family (both of the receptors are recognized by the same
antibody and both bind to HLA-C "group 2" antigens) are virtually identical in their
extracellular domains but differ in the length of their cytoplasmic tails (Moretta et aI.
1997). Inhbitory NK cell receptors have in their cytoplasmic domain a motif known as the
immunoreceptor tyrosine-based inhibitory motif (ITIM. The short cytoplasmic tails of
activatory NK cell receptors lack the ITIM sequence. ITIM is characterized by the amino
acid sequence (V /I) XY, which is involved in the recruitment of SH2 domain-
containing tyrosine phosphatases (SHP) (Thomas, 1995). SHP has been implicated to play
an important role in the negative regulation of many immunoreceptors (Thomas, 1995).
This negative regulation of immunoreceptors by SHP can be appreciated in the motheaten
mice, which harbor a mutation in the SHP gene. Motheaten mice have numerous
immunological disorders, including chronic macrophage and neutrophil disorders
lymphopenia and circulating autoantibodies (Schultz, 1991).
In the mouse, the ITIM sequence is also found in the Ly49 receptor family.
Recently, Nakamura et al showed that the inhibitory signal sent through the Ly49A NK
cell receptor utilzed the cytoplasmic phosphatase, SHP- , which binds to ITIM
(Nakamura et aI. , 1997). In SHP- I mutant viable motheaten mice and SHP- deficient
motheaten mice the Ly49A function in NK cells is impaired. It is also demonstrated that
the mutation of the tyrosine site within the proposed SHP-I binding motif of Ly49A
abrogates the inhbition of NK cell cytotoxicity through this receptor (Nakamura et aI.
1997). These results allow us to arbitrarily divide the NK cell receptors into 2 groups
activatory or inhbitory, based on the presence or absence of the ITIM sequence. Table 1-
is a summary of some of the known mouse and human NK cell receptors.
Investigators working on the identification of the Cmv- gene product have
indicated that Cmv- is closely linked to the Ly49 receptor family, suggesting that Cmv-
may be an existing or undefined member of the Ly49 multigene family (Brown et aI.
1997). Figure 1- 1 depicts the relative position ofCmv- in the mouse NK gene complex.
Members of the Ly49 NK cell receptor family have been to shown to interact with MHC
class I molecules (Leibson, 1995; Yokoyama, 1995a). The interactions between Ly49A, C
or G2 with their respective MHC class I ligands have an inhibitory effect on the NK cells
whereas the Ly49D NK cell receptor activates the NK cells (Yokoyama, 1995a; Mason et
, 1996; Raziuddin et aI. , 1996; Table I- I).
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Members of the Ly49 family have been shown to have physiological roles in bone
marrow transplants, especially in the phenomenon ofF 1 hybrid resistance (Sentman et aI.
1989; Yokoyama, 1995b; Yu et aI., 1996). FI hybrid resistance is the ability of H-
heterozygous mice to reject parental bone marrow grafts by NK cells. In FI hybrids, the
Ly49C+ NK cells (recognized by the Ab SW5E6), which bind to H- + cells have been
demonstrated to mediate the specific rejection of H- parental bone marrow cells
(Raziuddin et ai, 1996; Yu et aI. , 1996). In vivo depletion of 5E6+ NK cell subset
abrogates this rejection (Raziuddin et ai, 1996; Yu et aI., 1996). On the other hand
Ly49G2+ NK cells, which bind to H- + cells, are able to complement the Ly49C+ NK cells
by specifically mediating the rejection ofH- parental bone marrow allografts in FI mice
(Raziuddin et aI. , 1996). This rejection of parental bone marrow cells can be abrogated by
depleting the Ly49G2+ NK cell subset in FI mice (Raziuddin et aI. , 1996).
The role of Ly49 NK cell receptors in the regulation of virus infections is not
known. Recently it has been demonstrated that MCMV, like HCMV, encodes a MHC
class I homologue that may interfere with the ability of NK cells to regulate the virus
(Farrell et aI., 1997; Reyburn et aI., 1997). It is possible that MCMV may exploit the
inhbitory effects on NK cells caused by the binding of Ly49 NK cell receptors to class I
molecules by providing pseudo class I molecules to the NK cells.
MHC CLASS I EXPRESSION AN NK CELLS
Before the discovery of NK cell receptors and their interaction with MHC class I
molecules, the abilty of in vivo-stimulated NK cells to lyse allogeneic targets and target
cells that do not express MHC class I molecules was, in fact, initially used to differentiate
virus-induced NK cell-mediated killng from CTL-mediated lysis (Welsh, 1978; Welsh et
aI. , 1979; Kiessling and Welsh, 1980). The 'Missing Self Hypothesis ' proposed that the
susceptibility of target cells to NK cell-mediated lysis is inversely proportional to the
amount of class I molecules on the target cell surface (Ljunggren and Karre, 1990;
Sentman et aI. , 1995). Ljunggren et al showed that tumor cells that were class I negative
were rejected by the NK cells in their syngeneic host and that the induction of MHC class
Ion the cell surfaces after transfection of J32-microglobulin (J32m) into J32m negative (J32m
/-)) mutant tumor cells restored the tumorigenic potential (Glas et aI. , 1 992b). They also
showed that the IF-mediated resistance of cells to NK cell-mediated lysis was in part due
to the presence of class I molecules, as Y AC- I lymphoma J32m ) variants could only be
protected by IFs after transfection and expression of J32m which allowed for transport of
class I molecules in stable form to the cell surface (Ljunggren et aI., 1990). As the
interactions between most of the known NK cell receptors and MHC class I molecules
may have an inhbitory effect on the engaged NK cells, and because some virus infections
markedly alter MHC class I expression, it has been speculated that virus-induced
modifications of MHC class I expression on target cells may render the cells susceptible
to NK cell killng (Storkus and Dawson, 1991; Brutkiewicz and Welsh, 1995).
Virus-Induced Downregulation ofMHC Class I Molecules
Some viruses quantitatively alter the expression of MHC class I antigens by
directly down-regulating cell surface expression and/or by interfering with the ability of
IFs to upregulate class I molecules (Brutkiewicz and Welsh, 1995). During virus
infections in vivo the induced IFN- not only activates the NK cells but also
transcriptionally induces the expression ofMHC class Ion many of the cells in the infected
host (Bukowski and Welsh, 1985a; Bukowski and Welsh, 1986). This upregulation of
class I expression renders the uninfected host cells resistant to NK cell-mediated lysis and
more susceptible to allospecific CTL (Hansson et aI. , 1980; Bukowski and Welsh, 1986).
It has been suggested that an impairment of IFN-induced protection in virus-infected cells
may leave those cells susceptible to attack by the highly activated NK cells, while the
uninfected cells in the host would be protected from such attack (Trinchieri and Santoli
1978; Santoli and Koprowski, 1979; Bukowski and Welsh, 1986). A downregulation of
class I molecules or an inhibition of IFN-induced upregulation of class I molecules on
infected cells undoubtedly helps the virus to escape the immune surveillance by T cells, as
cells require the interactions between the viral peptide presented on MHC class I
molecules with their cell surface T cell receptors to be activated. Whether these alterations
directly infuence their susceptibility to NK cells in the context of a viral infection in vivo 
a question under investigation.
Mechanisms of Virus-Induced Downregulation ofMHC Class I Expression
Different viruses have evolved various mechanisms to quantitatively reduce cell
surface MHC class I expression, presumably in their attempt to escape CTL-mediated
lysis. Blocks in class I heavy chain transcription, class I assembly or class I transport are
some of the mechanisms described to date. HCMV infection affects the stability of class I
heavy chains (Beersma et aI. , 1993; Warren et aI. , 1994; Yamashita et aI. , 1994; Jones and
Sun, 1997). In the very early times post-infection, US3 glycoprotein, a 21 kDa immediate
early gene product of HCMV, sequesters MHC class I heavy chains predominantly in the
endoplasmic reticulum (ER). Subsequently, two early HCMV glycoproteins, US2 and
US 11 destablize the sequestered MHC class I molecules by misdirecting the class I
molecules ITom the ER to the cytosol for degradation by proteosomes (Jones et aI., 1995;
Hengel et aI. , 1996; Wiertz et aI. , 1996a; Wiertz et aI. , 1996b; Jones and Sun, 1997). This
retention and shunting of class I molecules out of the ER effectively prevents any form of
class I ITom being expressed on the cell surface.
MCMV prevents antigen presentation by blocking the transport of peptide-loaded
MHC class I molecules into the medial-golgi compartment (del Val et aI., 1992). This
block is carred out by MCMV' s early gene products, and, in contrast to HCMV, these
gene products also downregulate the synthesis of class I molecules but have no discernible
effect on the rate of class I degradation (Campbell and Slater, 1994; Thale et aI. , 1995).
Recently one of the early MCMV genes involved in the downregulation of MHC class I
molecules was isolated. mJ52 a 40 kDa type I transmembrane MCMV glycoprotein has
been shown to arrest the transport of mouse MHC class I molecules in the ER-golgi
intermediate compartmentlcis-golgi compartment (Ziegler et aI. , 1997). This arrest of class
I transport is specific as mI52 glycoprotein does not prevent the expression of human
MHC class I molecules (Ziegler et aI. , 1997). In addition to the its ability to prevent class I
expression, MCMV also inhibits the ability of IF to upregulate class I expression
(Campbell and Slater, 1994).
In HSV- infected cells, class I molecules are not transported to the cell surface
early in infection under conditions where class I synthesis remains normal (Hill et aI.
1994). This class I deficiency is due to the HSV- l immediate early gene product, ICP47
which blocks the presentation of viral and endogenous peptides to the CTL by physically
associating with the transporter associated with antigen presentation (TAP), effciently
blocking the transport of pep tides by TAP into the ER (Fruh et aI. , 1995; Hil et aI. , 1995).
This block in peptide transport into the ER prevents normal MHC class I complexes to
form and thus not be expressed on the cell surface.
Human immunodeficiency virus 1 (HIV - 1) has been reported to downregulate
class I antigens in a CD4+ T cell line. The defect in the expression of class I is not due to a
block in the transport or the assembly of class I molecules but is instead due to HIV - 1 tat
protein-induced reduction in class I heavy chain transcription (Scheppler et aI. , 1989). In a
separate report, HIV- I Nefprotein is also shown to downregulate MHC class I expression
in the same CD4+ T cell line, as well as in monocytic and epithelial cells. MHC class I
transcription is not reduced in Nef-expressing cells, but the expression of Nef stimulates
the rapid internalization and accumulation of cell surface class I molecules in the
endosomal vesicles, which are subsequently degraded (Schwartz et aI. , 1996; Mangasarian
et aI. , 1997). As tat may control Nef gene expression at the transcriptional level , these 2
vial gene products may work in concert to downregulate MHC class I expression (Cullen
and Greene, 1989).
In Burkitt' lymphoma cells or Epstein-Barr (EBV)-transformedvIruS
lymphoblastoid cell lines, there is a selective downregulation in the expression of one of
several class I alleles (Masucci et aI., 1987; Masucci et aI. , 1989; Imreh et aI. , 1995).
Mutational analyses revealed that the internal glycine-alanine repeat of EBNAI , an EBV
nuclear protein, has the ability to inhibit antigen processing and MHC class I presentation
(Levitskyaya et aI. , 1995).
Adenovirus subgroups B through E prevent the expression of class I complexes by
binding the E3 19 KDa glycoprotein to class I molecules and retaining them in the ER
(Wold and Gooding, 1991; Hermiston et aI., 1993). The EIA protein of adenovirus
subgroup A, like HIV - 1' s tat protein, interferes primarily through the downregulation of
class I heavy chain mRA transcription (Friedman and Ricciardi, 1988; Shemesh et al.
1991;). A summary ofMHC class I downregulation by viruses is shown in Table 1-
Effects of Virus-Induced Downregulation ofMHC Class I Molecules on NK Cell-
Mediated Lysis
Although it is well-established that viral infections down-regulate class I
expression, it has not yet been clearly shown that this affects the sensitivity of virus-
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infected cells to NK cells. A correlation between MHC class I downregulation by different
strains of adenovirus and susceptibility of adenovirus-infected cells to NK cell-mediated
lysis was made in one report, but no further work has supported this claim (Dawson et aI.
1989). Cells infected by an adenovirus E3 mutant, which lacks the gene that retains class I
molecules in the ER, express normal levels of class I molecules on the cell surface that can
be further upregulated by treatment with IF-
y, 
similar to normal uninfected cells (Routes
1992). However, despite the high levels of class I molecules on the cell surfaces of IF-
treated E3-mutant-infected cells, these cells remain relatively susceptible to NK cell-
mediated lysis compared to untreated E3-mutant-infected cells and uninfected cells.
HIV - infected cells have enhanced sensitivity to lysis by NK cells, but the link has
not yet been made between this enhanced sensitivity to lysis and the HIV- I tat- or Nef-
induced downegulation of class I molecules (Ruscetti et aI. , 1986; Bandyopadhyay et aI.
1990). It is noteworthy that HIV -infected individuals have fewer NK cells than normal
subjects and that these NK cells have defective NK cell cytolytic activity (Bonagura et aI.
1992; Hu et aI. , 1995; Ullum et aI. , 1995). Therefore, even though HIV- infected targets
may be susceptible to NK cell-mediated lysis, NK cells in these individuals would have
poor ability to lyse the targets. It is possible that this HIV - induced defective natural
immunity contributes to the host's susceptibility to opportunistic infections and the
reactivation of herpes viruses thought to be controlled by NK cells (Biron et aI., 1989;
Ullum et aI. , 1995).
Substantial work has indicated that human fibroblasts infected with HCMV or
HSV- I are more susceptible to NK cell mediated lysis than uninfected cells (Ching and
Lopez, 1979; Borysiewicz et aI. , 1985). Evidence that this is related to class I molecules
was confned to one report showing that increased sensitivity ofHSV- infected targets to
NK cells was limited to cells expressing class I molecules and not to a class I negative cell
line, which was quite sensitive to lysis even when uninfected (Kaufman et aI. , 1992). It
has been speculated that the dowregulation of class I molecules by HSV -1 may have
clinical significance in gestating mothers infected with the virus. HSV infections can
sometimes be deleterious to the unborn child, as there is an association between the HSV-
1 infection and spontaneous fetal loss (Zdravkovic et aI. , 1994). Human trophoblasts do
not express the classical MHC class I molecules but instead express the non-classical class
I molecule HLA- , as well as a HLA- like molecule, HLA-CJED (Schust et aI. , 1996).
The interaction of HLA-G molecules and the p58 NK cell receptor proteins on cloned
human NK cells have an inhibitory effect on NK cell-mediated lysis (pazmany et aI.
1996). Recently it has been shown that HSV- I ICP47 blocks the intracellular transport of
HLA- , thereby preventing the expression of HLA-G on the cell surface of extravillous
cytotrophoblast cell lines (Schust et aI. , 1996). It has been speculated that this prevention
of HLA-G molecules ITom expressing on the cell surface may be linked to spontaneous
fetal loss during HSV - 1 infection, as the extravilous cytotrophoblasts would not be
protected ITom maternal NK cell-mediated lysis. More information is required to evaluate
this hypothesis.
Qualitative Alterations in MHC Class I Molecules Associated with Insertion of
Viral Peptides
A second mechanism by which viruses might alter MHC class I expression is by
the insertion of virus-encoded peptides into the class I peptide-binding groove. Studies
using site-directed mutagenesis on human MHC class I molecules and with MHC-
congenic strains of mice suggest that human and mouse NK cells interact with the class I
molecules near the antigen peptide-binding groove and the surrounding a-helices
specifically the al and a2 domains, which cradle the peptide (Karlhofer et aI., 1994;
Kurago et aI., 1995). Indeed, cloned NK cells have been shown to be inhibited by self
peptides in the context of self MHC molecules (Correa and Raulet, 1995; Malnati et aI.
1995). These results suggest that the selfpeptides presented by the class I molecules may
be important in the inhibition ofNK cell lysis and lead to the hypothesis that the insertion
of foreign (i.e. viral) peptides into the peptide-binding groove may interfere with this
interaction and render a virus-infected cell sensitive to NK cell killng. Studies on the
sensitivity of target cells to lysis by NK cells after treatment of targets with
immunodominant viral peptides for CTL have led to conflicting results. One study
suggested that an influenza virus peptide enhanced the susceptibility of concanavalin A
(Con A)-induced lymphoblasts to syngeneic NK cells (Chadwick et aI. , 1992). A second
conficting report showed that under conditions that would sensitize target cells to CTL
killng, immunodominant T-cell peptides from several viruses including infuenza failed to
sensitize these target cells to NK cell-mediated lysis (Brutkiewicz and Welsh, 1995).
Studies using the Ly49A+ NK cell subset and TAP-mutant RMA-S cells transfected with
showed that any of a variety of pep tides that enabled the H- molecule to form a
stable complex on the cell surface delivered a negative signal to Ly49A+ NK cells (Correa
and Raulet, 1995). A recent report showed that empty MHC class I molecules which can
be stably expressed on RM-S cell surfaces at 26 C are suffcient to confer protection to
the target cells, implying that polymorphic structures on the class I molecules and not the
peptides that are interacting with the NK cells (Mandelboim et aI. , 1996). It is thus likely
that when peptides do alter the sensitivity of targets to NK cells, it is not because they are
recognized by NK cells per se, but because they either change the conformation of the
class I molecule or destabilze it on the cell surface.
Whether or not the insertion of immunodominant or even non- immunodominant
peptides into MHC class I during a viral infection will alter the negative signal to NK cells
and render a virus-infected target preferentially susceptible to NK cell-mediated lysis
remains unclear. As VV -infected target cells become sensitive to lysis by VV -specific
CTL, the infected targets have a period in time when they display enhanced sensitivity to
NK cell-mediated lysis and markedly reduced sensitivity to killng by allospecific CTL
even though the quantitative expression of class I antigens remains high; it was suggested
that the replacement of endogenous peptides presented by the MHC molecules by foreign
VV -encoded peptides may have abrogated the abilities of class I molecules to 
recognized properly by either allospecific CTL or NK cells (Brutkiewicz et aI. , 1992). In a
second similar study, HSV - 1 infection was found to enhance the NK cell-sensitivity of
class I-deficient CIR cells transfected with class I genes but had no effect on the NK cell-
sensitivity of non-transfected cells (Kaufman et aI., 1992). This enhanced sensitivity
occurred under conditions where class I expression remained high on the cell surface
leading again to the speculation that viral peptides may have replaced endogenous
peptides in the expressed class I molecules. While suggestive, neither of these studies
formally proved the hypotheses.
NK CELLS AS EFFECTOR CELLS AGAIST PARSITIC INECTIONS
In vivo and in vitro evidence has indicated that NK cells can contribute to the early
resistance against Toxoplasma gondii, Leishmania major and Schistosoma mansoni
infections by producing IF-
y, 
which stimulates microbicidal activity in macrophages. To
date there is little evidence of direct NK cell-mediated killng of parasites or parasite-
infected cells. T. gondii- infected IF- knockout mice or C57BL/6 mice treated with anti-
IF- Abs have good NK cell activity but cannot control the infection, whereas beige
mice deficient in NK cell cytotoxic activity can control the parasitic infection (pazmany et
aI., 1996). The first example of a protozoan stimulating the production of T cell-
independent IF- was shown using T. gondii (Sher et aI. , 1993). In vitro studies showed
that SCID mouse splenocytes exposed to live tachyzoites of T. gondii or to just soluble
parasitic extracts could be stimulated to produce high levels of IFN-y (Sher et aI. , 1993).
Spleen cells ITom SCID mice when treated with anti-aGM antisera, which deplete the NK
cells, did not produce IF-
y, 
suggesting that it was the NK cells that were the source 
the IF-y. In vivo the depletion of IF- or NK cells in T. gondii- infected SCID mice
abrogated the resistance to the parasite, adding further evidence that NK cell-produced
IF- is essential in the regulation of T. gondii (Gazzinell et aI., 1993). The protection
afforded by NK cells in the early resistance to T. gondii was examined in J32m /-) mice
(Denkers et aI. , 1993). Depletion of NK 1. 1 + cells in J32m /-) mice enhanced the growth of
the parasite, whereas the depletion of CD4+ or CD8+ T cells had no effect on this early
resistance. As in the MCMV infection, NK cell-produced IF- during T. gondii infection
requires the help of macrophage-produced IL- I2 and TN-a. (Gazzinell et aI. , 1993).
IF- produced by NK cells also contributes to the early innate resistance to 
major and S. mansoni. In vivo depletion of NK cells in C57BL/6 mice with anti-NKI.
Abs reduced the amount of IF- produced, resulting in enhanced growth of L. major
(Laskay et aI. , 1993; Scharton-Kersten and Scott, 1995). In S. mansoni- infected C3H and
C57BL/6 mice, depletion ofNK cells or IFN-y resulted in increased parasitic burden and
granuloma formation (Wynn et aI. , 1994).
In addition to providing resistance to parasites during the early phase of infection
NK cells can also modulate the adaptive immune response. The depletion of NK cells
IF- or IL- I2 ITom S. mansoni- infected C3H or C57BL/6 mice resulted in the skewing
of the initial Th1 response to a Th2 response (Oswald et aI., 1994; Wynn et aI. , 1994)
The same principle was true for L. major- infected mice, as the removal of NK cells
decreased IF- levels and promoted IL-4 production, leading to higher parasitic burden
and lesion development (Scharton and Scott, 1993). Depletion of aGMt, CD3- cells or
IL- I2 in the genetically resistant C3H mice infected with L. major abrogated NK cell-
produced IF-
y, 
causing the mice to mount a Th2 response rather than the usual Th 
response (Scharton-Kersten et aI., 1995; Scharton-Kersten and Scott, 1995). BALB/c
mice cannot control L. major infection because they are genetically predisposed to mount
a Th2 response to the parasite. Administration ofIL- I2 promoted CD4+ Thl development
in L. mqjor-infected BALB/c mice, and these Thl cells failed to develop if the NK cells
were depleted at the time of infection (Monso et al. , 1994).
NK cells are not always a determining factor in modulating Th 1 versus Th2
responses, as removal of NK cells in Candida albicans- infected C57BL/6 mice or in 
major- infected C3H mice stil allowed for the development of a Thl response (Romani et
aI., 1993; Scharton-Kersten and Scott, 1995). However, there stil was an increase in
parasite burden in the L. major-infected C3H mice because the Thl response was delayed
(Scharton-Kersten and Scott, 1995). Both C57BL/6 and C3H mice are naturally high NK
strains, and it is possible their high NK cell activity may predispose them to mount a Thl
instead of a Th2 response. The inability ofBALB/c mice to mount a Thl response may be
because BALB/c mice have low NK cell activity and their NK cells are poor producers 
IF- (Glas et aI., 1992b; Scharton and Scott, 1993). It would be interesting to see if
BALB/c mice made congenic with either the C3H or C57BL/6 NK gene complex would
have a Th 1 response instead of a Th2 response to L. major infection.
NK CELLS AS EFFECTORS AGAIST BACTERIAL INECTIONS
NK cells have been reported to have the capacity to be directly bactericidal and to
lyse bacterially-infected cells in vitro but the more likely way NK cells control bacterial
infections in vivo is by producing cytokines that activate the macrophages to degrade the
bacteria. Purified human NK cells when mixed with Salmonella typhimurium were shown
to inhbit the outgrowth of the bacterial colonies (Garcia-Penarrubia et aI. , 1989).
Macrophages when exposed to bacteria or bacterial products are stimulated to produce
NK cell-activating cytokines such as IFN- , IL- I2 and TN-a, which in turn activate
the NK cells to kill NK-sensitive targets (Wolf et aI. , 1976; Wold and Gooding, 1991;
Guo et aI. , 1992). Direct incubation of NK cells with fixed bacteria can also activate the
NK cells to kill NK-sensitive targets (Tarkkanen et aI. , 1986). NK cells have been shown
to lyse S. typhimurium-, Mycobacterium avium complex-, and Shigella jlexneri-infected
cells in vitro (Kimpel et aI. , 1986; Katz et aI. , 1990; Griggs and Smith, 1994). However
experimental evidence in vivo has suggested that NK cell-produced cytokines are probably
more important than the cytotoxic potential of NK cells in the control of bacterial
infections. Listeria monocytogenes, M avium and S. typhimurium infection in mice can
stimulate the production of IF- by NK cells, and this stimulation, as with viruses and
parasites, requires factors produced by macrophages (Ramarathinam et aI. , 1993; Tripp et
aI. , 1993; Appelberg et aI. , 1994). L. monocytogenes infection in SCID mice induces the
production of TN-a and IL- I2 from macro phages, and these cytokines subsequently
activate the NK cells to produce IF- (Tripp et aI., 1993). Neutralization of IL- , the
cytokine that induces the production ofIF-y, decreases the resistance to listeria in SCID
mice, indicating the importance of NK cell-produced IFN-y in the regulation of this
intracellular bacterial infection (Tripp et aI. , 1994).
IF-y-mediated resistance to mycobacterial or listerial infections may involve the
production of NO by macrophages and other cells (Glesch and Kaufiann, 1991;
Beckerman et aI. 1993). iNOS-deficient mice cannot control L. monocytogenes
replication (MacMicking et aI., 1995). The production of NO in L. monocytogenes-
infected SCID mice is dependent on NK cell-produced IFN-y, and inhibitors of NOS, W-
monomethyl arginine or aminoguanidine inhibited the production of NO and increased the
titers oflisteria in these mice (Beckerman et aI. , 1993).
Even though there is strong evidence showing that the depletion of NK cell-
produced IF- increased the susceptibility of immunodeficient SCID mice to L. major
infection, several studies using normal mice have ironically suggested that the depletion 
NK cells increased host resistance to the bacteria. Depletion ofNK cells in C57BL/6 mice
by anti-NKI. I mAb increased the resistance to L. monocytogenes (Takada et aI. , 1994).
This result is surprising, as IF- has been shown to be important for the control of the
listerial infection, and anti-NK 1. 1 treatment decreases the number of IF-y producing
cells (Teixeira and Kaufiann, 1994). An explanation for this may reside in competition
between host effector functions. One study suggests that NK cells may be inhibiting the
proliferation of yo cells that may play a role in the enhanced clearance of 
monocytogenes in the early stage of infection (Takada et aI. , 1994) and a second study has
shown that the presence of NK cells may inhibit the accumulation of neutrophils in
bacterially-infected lesions (Newton et aI. , 1992).
OBJECTIVE OF THE THESIS
The major focus of this thesis project was to determine how NK cells regulate
virus infections in vivo. The mechanisms used by NK cells in the early stages of virus
infections were not well defined, and one of the major goals was to study the in vivo
mechanisms by which NK cells regulate MCMV infections in adult mice as well as in
suckling mice. The discovery of the innate MCMV resistance gene Cmv- and the
disparity in the spleen and liver regulation of MCMV in C57BL/6 and BALB/c mice
stimulated us to also ask if NK cells used different mechanisms to control MCMV 
different organs and if subsets of NK cells with the ability to use different mechanisms
traffck to different organs to control the infection in that organ. As mouse genetic studies
had indicated that the gene Cmv- was found within the mouse NK gene locus, the second
objective was to test the importance of mouse NK cell receptors and MHC class I
molecules in the control of MCMV by NK cells. The specific aims discussed in this thesis
are as follows:
1. What are the mechanisms utilzed by NK cells to regulate MCMV infections in adult
C57BL/6 mice?
2. What are the mechanisms utilized by NK cells to regulate MCMV infections in
suckling mice?
3. What role does the innate MCMV resistance gene Cmv- , play in the regulation of
MCMV by NK cells in the spleen and the liver?
4. Do the members of the Ly49 NK cell receptor family play any roles in the in vivo
regulation ofMCMV by NK cells?
5. Do the interactions between MHC class I molecules and NK cells influence the ability
of the NK cells to control virus infections?
CHAPTER II
MA TERILS AND METHODS
CELLS
Y AC- I is a highly NK-sensitive Moloney leukemia virus-induced lymphoma cell
line ITom A/Sn mice. DIR and RIE. cells were derived from R1.1 (thymoma cells from
C58/J mice) and RIE (J32m-deficient derivative ofR1.I) cells respectively, and transfected
with the H- gene (Allen et aI., 1986; Waneck et aI., 1987). Y AC- cells were
cultivated in suspension in RPMI 1640 medium (Sigma, St. Louis, Mo.) supplemented
with 10% fetal bovine serum (FBS) and antibiotics (Complete RPMI). DIR and RIE.D
were grown in the above medium additionally supplemented with 500 mglml of G418
(GIBCO/BRL, Gaithersburg, MD). DIR and RIE. cells were kindly provided by Dr. G.
Waneck, Massachusetts General Hospital. Mouse embryonic fibroblasts (MEF) and vero
cells (monkey kidney cells) were cultivated as monolayers in MEM (Gibco Laboratories
Grand Island, NY with antibiotics and 20% or 10% FBS , respectively.
GENERATION OF MEF
MEF were generated from 12 - 14 day pregnant C57BL/6 mice. The embryos
were aseptically removed, and only the torsos were used, The torsos were minced using a
pair of dissecting scissors and the resulting mixture was treated for 1 hour at 37 C in
05% trysin (GffCO BRL, Grand Island, NY). MEM with 20% FBS and antibiotics
were then added to the mixture and were used to seed TI50 flasks (Falcon, Newark, NJ).
Afer 4 - 5 days of culture, cells adhering to the bottom of the flasks were removed and
expanded. Confluent monolayers of MEF formed after first passage were removed using
05% trypsin and were ITozen in liquid nitrogen for future use.
MICE
C3H/eSnJ (H_ ), C57BL/6 (H- ) and BALB/c (H- ) mice were purchased
ITom The Jackson Laboratory, Bar Harbor, ME. These mice were conventionally housed
and were used at 6 - 12 weeks of age. Breeder pairs of mice homozygous for a targeted
mutation disrupting the gene for J32m, originally derived by Drs. B. Koller and O. Smithies
(Koller et aI. , 1990), University of North Carolina, Chapel Hill, NC, were kindly supplied
by Dr. D. Roopenian (The Jackson Laboratory, Bar Harbor, ME). Breeder pairs of 129
wild type control and 129 mice homozygous for a targeted mutation disrupting the mouse
interferon gamma receptor gene (IF- 0/o were originally derived and kindly supplied by
Dr. M. Aguet, University of Zurich, Switzerland (Huang et aI. , 1993). Breeder pairs of
129 x C57BL/6 mice heterozygous for a targeted mutation disrupting the gene for perforin
were originally derived and kindly provided by Drs. C.M. Walsh and W.R. Clark
University of Californa, Los Angeles (Walsh et aI. , 1994). FI offspring of the above
heterozygous breeding were typed using PCR. J32m (-/-) mice, perforin deficient (perf orin
0/0) and IF- 0/0 mice and their respective wild type controls were housed in a specific
pathogen ITee (SPF) environment and were used at 6 - 12 weeks of age. Suckling mice of
C57BL/6, 129 and 129/I- 0/0 background were used at 4 - 6 days of age in the
adoptive transfer experiments.
VIRUSES
To generate stocks of the Smith strain of MCMV, 6 week old BALB/c mice were
injected i.p. with 5 x 10 PFU MCMV. The mice were sacrificed two weeks post-
infection, and the salivary glands were removed. The salivary glands were ground using a
mortar and pestle, and the resulting mixture was centrifuged at 2000 rpm at 4 C for 20
min. The supernatant was removed, aliquoted and stored at - C. MCMV, which is an
NK cell-sensitive virus (Bukowski and Welsh, 1985b; Bukowski et aI. , 1985), was titrated
by plaque assay on MEF. MCMV was given to adult and suckling mice i.p. at a dose of 1
- 3 X 10 PFU/adult mouse and 2 x 10 PFU/suckling mouse 3 days before use.
The Arstrong strain ofLCMV was propagated in BHK21 cells. LCMV, which is
an NK cell-resistant virus (Bukowski and Welsh, 1985b; Bukowski et aI. , 1985), was
titrated by plaque assay on vero cells. LCMV was given i.p. at a dose of 5 x 
PFU/mouse 3 days before assay.
PLAQUE ASSAYS
MCMV and LCMV were titrated by plaque assay on MEF and vero cells
respectively. Organs ITom MCMV- or LCMV-infected mice were removed and stored at-
C in complete RPMI. On the day of the plaque assay, the organs were ground using a
mortar and pestle and the mixture was centrifuged at 2000 rpm at 4 C for 20 min. The
clarified supernatant was removed and was used to titrate the virus on the appropriate
cells in 6 well plates (Costar, Cambridge, MA). Ten fold dilutions of 1 00 l were added to
the cells in 1 ml of media and incubated for 90 min at 37 C with occasional agitation. A
1:1 mixture of 1% Seakemp agarose (FMC , Rockland, ME) and EMEM (BioWhittaker
Walkersvile, MD) supplemented with antibiotics (overlay mixture) and 40% FBS (for the
titration ofMCMV on MEF) or 10% FBS (for the titration of LCMV on vero cells) was
overlayed onto the cells. The plates were incubated at 37 C for 5 days (MCMV) or 4 days
(LCMV). To visualize MCMV plaques, the agarose overlays were removed, and the cells
were stained with 0. 1% crystal violet (Sigma, S1. Louis, MO) in 1% formaldehyde (Banco
Fort Worth, TX)-PBS solution. To visualize LCMV plaques, 0. 1 % neutral red (Sigma, St.
Louis, MO) was mixed with the overlay mixture and added onto the initial agarose overlay
3 days post-assay. LCMV plaques were read on day 4.
INCTIVE CENTER PLAQUE ASSAYS
Infective center plaque assays were done by using a modification of the routine
plaque assays. Spleens ITom virus-infected mice were aseptically removed and single cell
suspensions were prepared using complete RPMI. One milion spleen cells suspended in 
ml of media were added to the appropriate cells (MEF for MCMV and vera cells for
LCMV) in 6 well plates and incubated for 4 hours at 37 C. Care was taken to make sure
that the plates were not agitated during incubation. The plates were then washed 3 times
to remove the spleen cells before the overlay mixture was added. The plates were
incubated at 37 C for 5 days (MCMV) or 4 days (LCMV). Visualization of the plaques
were the same as in the routine plaque assays.
CYTOTOXICITY ASSAYS
Standard 4 - 6 h 
51 Chromium-release microcytotoxicity assays (Bukowski et aI.
1985) were used to determine NK cell activity on various targets. Target cells (1 x 10
were incubated with 20 J.Ci ofNa Cr04 (5 mCi/ml, Dupont NEN, Boston, MA) for 
hour at 37 C. The targets were then washed 3x in warm complete RPMI, and YAC- I and
other cultured cells were used at 10 targets/well and at a variety of E:T ratios. To avoid
the high spontaneous release of , thymocyte targets were used at 4 x cells per
well. All assays were performed in bottom 96 well plates (Costar, Cambridge, MA).
IMM REAGENTS
Rabbit antiserum to aGM (Wako Labs, Dallas, TX) was used at a pretitrated dose
which depleted LCMV-induced NK cell activity but not CTL activity in C57BL/6 mice.
Anti-aGM was inoculated into mice i.p. 12 h prior to or on the day of infection
(Bukowski et aI. , 1983). Poly I:C was purchased from Sigma Chemical Co. , St. Louis
, and was inoculated Lp. into mice at a dose of 100 !Jg/mouse 2 days before assay.
Mouse IF J3 was purchased ITom Lee Biomolecular, San Diego, CA. IF J3 was used at
1000 U/ml to treat the appropriate cultured cells for 24 h at 37 C prior to assay. The anti-
NK1.1 mAb, PK136 (provided by Dr. G.C. Koo, Merck Sharpe and Dohme Research
Laboratories, Rahway, NJ) (Koo and Peppard, 1984), was produced in ascites using
BALB/c mice, and then NRS04-cut and affnity-purified before use. PK136 was
inoculated into mice Lv. via the retro-orbital sinus at a dose of 200 !JI of a 1:40
dilution/mouse 24 hours before the day of infection. The anti-IF-y mAb , R46A2, was
obtained ITom American Type Culture Collection, Rockville, MD, and was inoculated i. 
in ascites form at 200 
III of a 1: 5 dilution/mouse on the day of infection, and at day 1 and
day 2 after infection. By ELISA, the amount of anti-IFN-y ascites given in 3 days was
enough to bind 0.9 Ilg/ml of recombinant mouse IFN-y (pharmingen, San Diego, CA). 
vivo depletion of CD4+ T cells was done by injecting i. p. 80 III of a rat anti-mouse CD4
mAb in undiluted ascites (clone GK1.5). CDS+ T cells were depleted by injecting i.p. 100
III of a 1:40 dilution of an ascites preparation of rat anti-mouse CD8 mAb (clone 2.43).
Clone 2.43 was provided by Dr. R. Fujinami, University of Utah, UI, and clone GK1.5
was purchased from American Type Culture Collection, Rockvlle, MD. The anti-CD4 and
anti-CD8 mAbs were routinely used in our laboratory at these concentrations to deplete
CD4 and CD8 cell numbers as well as virus-induced CTL activity in vivo. Anti-Ly49G2
ascites, 4Dll (Hazelton Technologies), was given iv at a dose of 200 J.g/mouse 1 day
before virus infection. Anti Ly49D ascites, 12A8 , was given iv at a dose of300 J.g/mouse
at day -2 and day -1. 4Dll and 12A8 Abs were provided by Dr. J.R. Ortaldo, NCI
Frederick, MD. Anti-Ly49C ascites, 5E6 , and anti-Ly49A ascites were given iv at a dose
of 2 mg/mouse and 100 J.1 of a 1:2 dilution/mouse, respectively, 1 day before virus
infection. Anti-Ly49A and anti-Ly49C Abs were provided by Dr. V. Kumar, University of
Texas, Southwestern, Dallas, TX. The Ly49 antibodies were used at the doses
recommended by our collaborators (Drs. V. Kumar and lR. Ortaldo), who had titrated
the antibodies in vivo to ensure the depletion of the respective NK cell subsets.
OFLUORESCENCE
The rat anti-mouse H-2 class I mAb MI (clone MI/42. HLK) is panreactive
for all mouse H- class I molecules except H- . The 28- 11-5S and the 28- 14-
hybridomas produce anti- b alloantibodies that recognize conformation-dependent and
conformation-independent determinants, respectively (Townsend et aI. , 1989). Clone MI
28- 11- , and 28- 14-8S were obtained from the American Type Culture Collection
Rockvlle, MD. Fluorescein isothiocyanate (FITC)-labelled goat anti-rat IgG + IgM (H+L)
and FITC-Iabelled goat anti-mouse F(ab)'2 Ig antiserum were purchased ITom Jackson
Immunoresearch, West Grove, PA. Clone MI , 28- 11-5S and 28- 14-8S were used at 200
IlVI0 cells. Cells were incubated with the above antibodies for 30 min. on ice, washed
and FITC-Iabelled goat anti-rat IgG + IgM or FITC-Iabelled goat anti-mouse F(ab)'2 Ig
antiserum were added. The- cells were then incubated for another 30 min. before they were
washed again and fixed with 4% paraformaldehyde for 10 min in room temperature. Afer
the final wash, the cells are kept at 4 C until FACs analysis by the Univ. of Massachusetts
Medical Center (UC) FACs facility.
FITC-Iabelled anti-CD8 and phycoeryhrin (PE)-labelled anti-CD4 were purchased
ITom GffCO/BRL, Grand Island, NY. PE-Iabelled anti-ThyI.2 mAb, FITC-labelled B220
mAb, PE-labelled anti-NK1.1 mAb, FITC-Iabelled anti-Ly49A mAb and FITC-Iabelled
Ly49C mAb were purchased ITom Pharmingen, San Diego , CA. The antibodies were used
according to manufacturer s specifications. FITC-Iabelled anti-Ly49D (12A8) (50 III 
1:80/10 cells) and FITC-Iabelled anti-Ly49G2 (4DII) (50 III of 1:40 dilution/10 cells)
were provided by Dr. J.R. Ortaldo, NCI, Frederick, MD. Cells were incubated with the
antibodies for 30 min on ice before they were washed and fixed with 
paraformaldehyde for 10 min in room temperature. Afer the final wash, cells stained with
these directly labeled antibodies were kept as above before F ACs analysis.
To sort the lymphokine activated kiler (LAK) cells into the different Ly49 NK cell
subsets, LAK cells were stained with PE-Iabelled anti-NK1.1 mAb and one of the 4 FITC-
labelled anti-Ly49 antibodies at a concentration stated above, The stained cells were
washed once, resuspended in RPMI- I640 supplemented with 4% FBS and antibiotics, and
were immediately sent to the UMC F ACs facility for sorting. Typically, the sorted cells
were 90% - 99% pure for the respective population.
Anti-Ly49D (I2A8) Ab used in the in vivo depletion studies and the adoptive
transfer studies was cross-reactive with Ly49A NK cell receptor. However a different
FITC-Iabelled anti-Ly49D Ab which was not cross-reactive with Ly49A receptor was
used in the study ofNK cell distribution. This Ab was used at a concentration 50 JJI of a
1: 1000 dilution/I0 cells.
To stain for MHC class II antigens on macrophages, 5 x 10 splenocytes were first
treated with a rat monoclonal antibody, J1ID (33 f.l of 1:3 dilution) (Bruce et aI. , 1981;
Natuk and Welsh, 1987a), + rabbit complement (pel Freeze Chemical Inc. , Brown Deer
WI) to remove the B cells and granulocytes. The residual cells were pre-treated with
normal mouse serum for 10 min. and then stained with mouse anti-mouse I- FITC
(pharmngen, San Diego, CA).
GENERATION OF LAK CELLS
Ten ml syringes (Becton Dickinson & Company, Franklin Lakes, NJ) packed with
8 - 1.0 g nylon wool (polysciences Inc, Warrington, P A)/syringe were used to generate
LAK cells. The columns were first rinsed with 20 ml of prewarmed RPMI 1640 (Sigma
St. Louis, MO), supplemented with 10% FBS, L-glutamine, antibiotics, non-essential
amino acids, sodium pyruvate and 2-mercaptoethanol (MLC media). The columns were
then filled with MLC media to cover the nylon wool and any air bubbles trapped within
the columns were removed. The columns were incubated for at least 30 min or until use at
C to allow the nylon wool to equilibrate with the media. In the above preparation
steps, 18 gauge needles (Becton Dickinson & Company, Frankin Lakes, NJ) were used
for rinsing the nylon wool. Six to eight week old C57BL/6 spleens were aseptically
excised, and a single cell suspension was prepared using MLC media. Splenic leukocytes
were washed, and 1 x 10 cells at a concentration of 5 x 10 cells/ml were incubated on a
nylon wool column for 45 min at 37 C. Afer incubation, nylon wool non-adherent cells
were eluted at a rate of 1 drop/second with prewarmed media and then cultured in MLC
media supplemented with 800 U/ml of recombinant human IL-2 (Cetus Corporation
Emerylle, CA) at a density of 2 x cells/ml in 60 x 15 mm tissue culture dishes
(Becton Dickinson, Franklin Lakes, NJ). The elution step was performed using a 26 gauge
needle (Becton Dickinson & Company, Franklin Lakes, NJ). Afer the initial 3 days of
culture, only the adherent cells were expanded using the MLC media supplemented with
800 U/ml of recombinant IL-2 for another 4 - 6 days before use.
ADOPTIVE TRASFERS
Adoptive transfer experiments were done by using a modification of a method
previously described (Bukowski et aI., 1985). Four to six day old suckling mice were
pooled and randomly assigned to lactating females. Groups of 4 - 10 mice were given 5 x
LAK cells/mouse or 5 x 10 mouse spleen cells/mouse i. p. in 0. 1 ml of complete RPMI
using a I-ml syrnge and a 30 gauge needle (both purchased ITom Becton Dickinson &
Company, Franklin Lakes, NJ). The following day, the suckling mice were challenged with
2000 PFU/mouse MCMV i.p. Three days post-infection, the mice were sacrificed and the
spleens were removed for virus titration.
REAGENTS
~-monomethyl-L-arginine (L-NMA) and N"' -monomethyl-D-arginine (D-NMA)
were obtained ITom Sigma Immunochemicals (St. Louis, MO). Both reagents except
where indicated were given i.v. at a dose of 5 mg/mouse on the day of infection, and at
day 1 and day 2 of the infection.
ISOLATION OF MOUSE TAIL DNA FOR PCR
Mouse tails approximately 1 em in length were taken ITom mice 6 weeks old or
less and cut into several pieces. The protein was digested in a 500 III solution containing
1 M EDTA, 0.05 M Tris- , pH 8. , 0. 5% SDS and proteinase K (final concentration
500 Ilg/ml) overnght at 55 C. At the end of the digestion, NaCI was added at a final
concentration of 150 ro. A phenol, chloroform and isoamyl alcohol mixture (25:24:1)
was added and the resulting mixture was microfuged at 14000 rpm for 5 min in the cold
(DNA extraction step). The aqueous phase was removed into a fresh tube, and the DNA
extraction step was repeated. Afer the second DNA extraction, NaCI with a final
concentration of 0. 5 M was added to the resulting aqueous phase before 100% ethanol at
room temperature was added. The solution was mixed by inversion and spun in the
microfuge at 14000 rpm for 15 min. The DNA pellet obtained after the first ethanol wash
was washed the second time with 100% ethanol to remove any residual salt. DNA
obtained afer a second wash was dried in a SpeedVac (Savant SVC- IOOH, Farmngdale
NY) for 15 min. TE was then added to solublize the dried DNA in a 37 C waterbath, and
the DNA solution was stored at -
TYPING OF PERF ORI-DEFICIENT MICE
The of the perforin follows:pnmers werepnmer sequences
CTCCGGTCCTTCCCAGTGA and TTCTTCCAGTTCCTTTCTCC (Ransom Hill
Bioscience Ramona CA). andNeomycin pnmer sequencesInc.
(ATGATTGAACAAGATGGATTGC and GACAAGAACCGGGCG respectively)
were provided by Dr. C.L. Sidman, University of Cincinnati Medical Center, Cincinnati
OH. The neomycin primers were made by Biosynthesis, Lewisville, TX, and were
provided by Dr. A.M. Baird, Harvard University, Cambridge, MA. PCR were performed
on the tail DNA obtained ITom the FI offspring of the perforin heterozygous breeding.
PCR were done in a 20 l volume, consisting of 7. l double distiled water, 4 l of
DNA, 0.4 l each of the perf orin primers (20 M stock), 108 ng/reaction of neomycin
primer 1 , 132 ng/reaction of neomycin primer 2, 2 IJI of lOX PCR Buffer II, 2 IJIIO 
dNTP (2. ro dATP, dCTP , dGTP and dTTP each), 2. 5 IJI of25 ro Mg + solution and
2 U of AmpliTaq DNA Polymerase (5 U/IJI). All the PCR reagents were obtained from
Perkin Elmer s GeneAmp PCR Core Reagents, manufactured by Roche Molecular
Systems Inc. , Branchburg, Nl. The 20 IJI reaction mix was layered with 20 IJI of mineral
oil, placed in the Peltier Thermal Cycler (Model PTC-2000, MJ Research, Inc.
Watertown, MA), and after 5 minutes at 94 , 35 cycles of the following were performed:
1 minute at 94 , 2 minutes at 56. C and 2 minutes at 72 C. This was followed by a 2
minutes at 33 C resting stage and varying lengths of time at 4 C. The reaction products
were then loaded onto a gel ( 2% Metaphor Agarose, FMC, Rockland, ME, mixed with
1 % Ultrapure Agarose, GilCO BRL, Gaithersburg, MD), and after electrophoresis, the
gel was stained with ethidium bromide and the DNA bands visualized by ultraviolet trans-
ilumination. The PCR would only amplifY the 145 bp neomycin band from the DNA of
perforin % and only the 414 bp perf orin band from the perf orin-intact mice. Tail DNA
ITom perf orin heterozygous mice was used as a positive control, and 2 bands
corresponding to the 414 bp perforin band and the 145 bp neomycin band were obtained
(Fig II- I).
GENERATION OF BONE MARROW CHIRAS
Bone marrow cells were obtained from 6 - 12 week old C57BL/6 mice by flushing
the femur with RPMI 1640 supplemented with 10% FE S and antibiotics. Prior to injection
1 2 3 4 
4 1 4 
145 bp
Figure IT- Typing of perf orin-deficient mice using PCR. Mice tail DNA was typed using
perf orin-specific and neomycin-specific primers in the same reaction vial. PCR will only amplifY
the 414-bp perf orin band ITom perforin +/+ and only the 145-bp perforin band ITom perforin
0/0 mice. Lane 1 100 bp PCR markers. Lane 2: No DNA control. Lane 3: Perf orin +/+ DNA.
Lane 4: Perforin +/0 DNA. Lane 5: Perf orin % DNA.
with bone marrow cells, 6 - 12 week old 129 or IFN 0/0 mice received 950 rads (1 rad =
01 gray) ofy-irradiation. The irradiated mice were allowed to rest for 1 hour before they
were injected i.v. with 5 x 10 bone marrow cells via the retro-orbital sinus. These bone
marrow-reconstituted mice were housed in microisolator cages and were given sterile food
and tetracycline-treated water and were used 6 weeks after reconstitution. The ability of
anti-NK1.1 mAb to deplete the NK cell activity in the reconstituted mice was used as an
indication that the bone marrow reconstitution with NK 1. 1 + C57BL/6 cells was complete
as the 129 strain does not express the NK1.1 antigen.
STATISTICAL ANALYSES
All the data shown except in Table III-2 were analyzed by Student's test for each
individual experiment. For Table III- , the calculation of the average loglO PFU increase
or decrease in MCMV titers compared to the appropriate controls, taking into
consideration all of the relevant experiments was determined. Data obtained from
individual mice were used, and a statistical test analyzing the variance (ANOV A) for
mixed models using restricted estimation by maximum likelihood (RML) was applied. All
computations were performed using the "Proc Mixed" procedure in the SAS statistical
software package (SAS, Cary, NC). The results are shown as average 10glO PFU :t SE in
the text and in Table III-
CHAPTER III
MECHANISMS OF MCMV REGULATION BY NK CELLS IN ADULT C57BL/6
MICE
The mechanisms utilized by NK cells to regulate MCMV infections in vivo have
until recently been poorly understood. Recent studies have indicated that NK cells
produce anti-viral cytokines like IFN-y to control the virus in the liver (Orange et aI.
1995; Orange and Biron, 1996a) but there are no reports on how the virus is regulated in
the spleen, another major organ of early MCMV infection. Findings by Scalzo et al have
shown that the Cmv- gene product, a non-MHC-linked resistance gene to MCMV which
maps within the NK gene complex (Scalzo et aI. , 1990; Scalzo et aI. , 1992; Scalzo et aI.
1995b), confers resistance to MCMV in the spleen but not in the liver. As the effects of
Cmv- are mediated by NK1.1 + cells, it is possible that NK cells may utilize a Cmv-
dependent mechanism to control MCMV in the spleen but another mechanism to control
the virus in the liver. To address this possibility, I examined MCMV infections in perforin
0/0 mice and IF- 0/0 mice, as well as in normal mice treated with anti-IF-y Abs in an
effort to delineate the mechanisms utilized by NK cells in the regulation of MCMV in
different organs. I wil show in this chapter that in Cmv- CS7BL/6 mice, there is a
dichotomy in the mechanisms utilized by NK cells in the regulation of MCMV in different
organs.
REPLICATION OF MCMV IN PERFORI +/+ AN % MICE
Perf orin is a key effector molecule in cell-mediated cytolysis mediated by CD8+ T
cells and NK cells, and the molecule has been shown to be important in the in vivo T cell-
dependent regulation of virus infections and in the clearance of tumors (Walsh et aI. , 1994;
Kagi et aI. , 1 994a). To study the role of perf orin in the early regulation ofMCMV by NK
cells, perforin +/+ and mice were infected with MCMV for 3 days, and the NK cell
activity and MCMV titers in the spleens and livers were measured. Spleen and liver viral
. titers were chosen, because these are the primary organs of infection early in the infection.
Figure 111-1 shows the NK cell activity elicited in these mice 3 days post infection.
Perforin +/+ mice had good NK cell activity, whereas the perf orin mice exhibited no
NK cell activity, confrmng both the genotype of these mice and the importance of
perf orin in cell-mediated cytolysis. Replication of MCMV in the spleens of perf orin 0/0
mice was in several experiments markedly elevated compared to perf orin +/+ mice (Table
III- I). Interestingly, in both strains of mice there was no appreciable difference in the liver
MCMV titers (Table III -1). In 4 experiments, perforin % mice had an average of 1. 8:t0. 4
10glO PFU more MCMV in the spleen than in the perforin +/+ mice 
(p 
= 0.0002; Table 111-
2). In the liver, there was a statistically insignificant 0. I:t0. 5 10glO PFU MCMV increase in
perf orin % mice when compared to perforin +/+ mice (Table 111-2). These results suggest
that perf orin plays an important role in the regulation of MCMV in the spleen but not in
12:1 25:1 50:1 100:1
EfT RATIO
Figure III- I. NK cell activity ITom perforin +/+ and perforin mice. Three days post-
infection, spleen cells ITom MCMV-infected perforin +/+ CO) and perforin % (8) mice
were used as effectors against Y AC- l targets in a standard 5- Cr release assay.
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the liver. Although the control of MCMV infection at 3 days has been shown to be
mediated by NK cells and not T cells (Bukowski et al., 1985; Bukowski et aI., 1984;
Welsh et aI. , 1994), in one experiment mice were depleted of T cells with mAbs to CD4
and CD8. Perf orin mice treated with the anti-CD4 and anti-CD8 mAbs also exhibited
similar splenic titer increases with no change in the liver MCMV titers when compared 
T-cell depleted perf orin +/+ mice (Table III- , Exp. 2).
EFFECTS OF ANTI-NK1.1 MAB TREATMENT ON THE REPLICATION OF
MCMV BY PERFORI % MICE
The results ITom the experiments performed above suggest that NK cells utilze
perf orin to regulate MCMV in the spleen but not in the liver. However, these mice were of
a mixed genetic background (129 x C57BL/6), and 129 mice and C57BL/6 mice have
different susceptibilties to MCMV infection (Scalzo et aI., 1995b). To prove that any
effects seen were indeed due to NK cells, the mice were first shown to express the NK1.1
antigen by immunofluoresence, and then they were depleted of NK cells to test for the
enhancement in virus titers. Results depicted in Table II-3 show that MCMV -infected
perf orin mice depleted of NKI. I + NK cells synthesized more virus in the liver
compared to MCMV -infected, NK cell-intact perforin % mice. However, splenic MCMV
titers remained the same in both sets of mice. In 3 experiments, the average 10glO PFU
increase in virus titers in the liver was 0. 6:t0. 2 10glO PFU 
(p 
= 0.0002; Table 111-2), while
Table II-3. Effect of Anti-NK1.1 mAb Treatment on the Regulation of MCMV
by Perforin +/+ and % Mice. a
Exp
Log lO PFU/or an + SDSpleen LiverGroup
Perforin % 4.4:!. 5:!.
Perfcirin % + anti-NK1.1 5:!. 0:.
Perforin % 9:!. 0:!.
Perforin % + anti-NK1.1 8:!. 5:!.
Perforin +/+ 5:!. 6:!.
Perforin +/+ + anti-NK1.1 6:!. 4.3:!.
Perforin % 4. 6:!. 4. I:!. 1 
Perforin % + anti-NK1.1 6:!. 5::.
a Age-matched perf orin +/+ and 
mice were given i. p. 5 x 10 MCMV PFU/mouse.
Anti-NK1.1 was given i.v. 1 day prior to infection.b Spleen and liver MCMV titers were measured using C57BL/6 MEF 3 days afer
infection.
. Virus titers increased significantly after NK cell depletion when compared to infected
controls, p ,0.01.
# Virus titers increased significantly after NK cell depletion when compared to infected
controls
, p 
, 0.005.
s Virus titers increased significantly after NK cell depletion when compared to infected
controls, p = 0. 08.
there was only a slight increase in MCMV titers in the spleens (0. 11:0. 3 10glO PFU; Table
TII-2) of anti-NKl.I-treated perforin % mice. These data suggest that at 3 days post-
MCMV infection, the virus in the spleen is controlled by perf orin, while in the liver
MCMV is controlled by NK cells in a perf orin-independent manner.
SPLENIC CELL TYPES INECTED WITH MCMV
To determne the phenotype of spleen cells are infected by MCMV in vivo
splenocytes ITom 3 day MCMV-infected C57BL/6 mice were sorted into Thy 1. 2 , B220
and ThyI. B220" populations. These cells were then placed into an infectious center
assay, and the number of productively infected cells were measured. All 3 cell types were
productively infected. In 2 experiments, more B220+ cells were infected by MCMV than
were Thy1.2+ cells (Exp 1: 61 PFUIl0 B220+ cells vs 11 PFU/I0 Thy1.2+ cells; Exp 2:
13.5 PFU/I0 B220+ cells vs 4. 5 PFU/I0 Thy1.2+ cells). In the only experiment
performed, ThyI.2-B220" cells were also infected by MCMV (Exp 2: 160 PFUIl0
Thy1.2- B220" cells). These results suggest that Band T cells can be infected by MCMV.
EFFECTS OF ANTI-IF-y TREATMENT ON MCMV REPLICATION IN
C57BL/6 MICE
One possible mechanism that NK cells can use to control MCMV in the liver is via
the production of anti-viral cytokines like IFN-y. IFN-y produced by NK cells protects the
liver against MCMV infection, and this protection can be abrogated by treating mice with
anti-IF-y Abs (Orange et aI., 1995). C57BL/6 mice were infected with MCMV and
simultaneously treated with anti-IF-y Abs to determne whether the depletion of IF-
would raise virus titers in both the liver and the spleen. Treatment of MCMV -infected
C57BL/6 mice with anti-NK 1. 1 mAb or anti-aGM antiserum depleted the NK cell activity
below the levels of the uninfected controls, while the NK cell activity of mice depleted of
IF- was similar to that of the infected controls (Figure 111-2). This shows that the anti-
IF- treatment had no effect on the virus-induced augmentation of NK cell activity,
results similar to that recently reported by Orange et al (Orange et aI. , 1995). However
the effector function ofNK cells in vivo was compromised, as MCMV- infected C57BL/6
mice depleted of IF- had more virus growth in the liver (Table 1II-4). In contrast, the
splenic titers remained the same as the infected untreated controls (Table 111-4). There was
an average of O. 7:!. 2 10glO PFU more MCMV in the livers 
(p 
= 0.0003) but only O. H:0.
10glO PFU more virus in the spleens of anti-IFN-y treated mice when compared to the
infected untreated controls (Table 111-2). The amounts ofMCMV present in the livers of
anti-IF- treated mice were similar to those in MCMV-infected mice that were either
given anti-NK cell Abs only (anti-NK1.1 or anti-aGM ) or a combination of anti-NK cell
Abs and anti-IF-y Abs (Table 111-4). Although anti-IF-y treatment had no effect on
splenic viral titers, mice that were given anti-NK1.1 Abs exhibited 1.6:t0.2 10glO PFU
more virus in the spleen compared to infected controls 
(p 
= 0.0003; Table III-2).
cl'
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Figure 111-2. NK cell activity from anti-IF- treated C57BL/6 mice. Three days post-
infection, spleen cells from uninfected (0), MCMV-infected (8), MCMV- infected, anti-
aGMI-treated (0), MCMV-infected , anti-NK1.1-treated (B), MCMV-infected, anti-IF-
treated (.6), MCMV-infected, anti-aGM1-treated, anti-IF- treated (.A) and MCMV-
infected, anti-NK1.1-treated, anti-IF- treated ('\) C57BL/6 mice were used as
effectors against Y AC- I targets in a standard 5- Cr release assay.
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To make sure that the anti-IF-y treatment was altering IF- induced functions
in the spleen, splenocytes enriched for macrophages ITom uninfected, MCMV -infected and
MCMV-infected, anti-IF- treated C57BL/6 mice were stained for MHC class II
expression, which MCMV -induced IFN-y has been shown to upregulate (Heise and Virgin
, 1995). MCMV infection increased MHC class II expression on spleen leukocytes, but
in MCMV-infected mice treated with the same dose of anti-IF-y Abs, MHC class II
levels on the spleen leukocytes were at the same levels as the uninfected control (Fig. 111-
3). This indicated that the anti-IF-y treatment blocked IF-y-mediated functions in the
spleen, yet it did not affect MCMV replication in that organ.
REPLICATION OF MCMV IN IFN- 0/0 MICE RECONSTITUTED WITH
C57BL/6 BONE MAROW CELLS
To further clarify the role of IF- in the in vivo regulation of MCMV, we made
use of the IF- 0/0 mice. These mice lack the receptor for IF-
y, 
and , even though they
retain the abilty to produce IF-
y, 
the cells in these animals cannot respond to that
cytokine (Huang et aI. , 1993). The 129 background of these knockout mice did not allow
us to perform satisfactorily direct analyses on the NK cell control of MCMV infection
because the 129 strain has a low NK cell activity and is NKl. rand Cmv- (Scalzo et aI.
1995b). Depletion of NK cell activity in these mice with anti-aGM antiserum led to only
marginal increases in the spleen and liver MCMV titers. In 5 experiments each with 4 - 5
mice/group, anti-aGMI-treated, MCMV-infected 129 mice had an average of 0. 5:10.4
H1i.Qlimm ilfi ::if;2. A Uninfected 
165%
MClv-infected
anti-IFN-y treated!
U" ,Ml. '
17j%
RELATIVE MEAN FLUORESCENCE
Figure IT-3. MHC class I expression of splenic macrophages. Spleen cells ITom unieced
(A), MCMV-inected (B), and MCMV-ineced, anti-IF- treated (C) mice were parially
enrched for macrophages by treatment with JlID plus complement and then staied with a
mouse anti-mouse I- FITC Ab. The number above the positive pea reflecs the percentage
of cells that staied positively for MHC class II expression.
10glO PFU increase in splenic titers and only 0. I:!0.2 10glO PFU increase in liver titers when
compared to infected controls. In 7 experiments, anti-aGM1-treated, MCMV -infected
129/I- 0/0 mice had only a 0. 2:!0. 2 10glO PFU increase in splenic titers and a O. I:!O.
10glO PFU MCMV decrease in liver titers when compared to infected controls. Scalzo et al
had shown that, in BALB/cmice congenic for CS7BL/6 Cmv- and the NK gene complex
susceptibilty of these mice to MCMV changed from a Cmv- to a Cmv- phenotype
(Scalzo et aI. , 1995a). Therefore, to circumvent the 129/Cmv- background problem, we
reconstituted the IF- 0/0 mice with CS7BL/6 bone marrow cells, thereby creating a
strain of mouse (B6 IF- 0/o that has CS7BL/6 NK cells, is Cmv- and retains its
IF-yR deficient phenotype, at least among cells not of the bone marrow origin.
Figure 111-4 shows the NK cell activity ITom B6 I29 and IF- 0/0
chimeras 3 days after MCMV infection, with or without anti-NK1.1 mAb treatment. Both
strains of mice exhbited robust NK cell activity, which was depleted with the anti-NK1.1
mAb. B6 129 mice depleted of NK 1.1 + cells had higher virus titers in both their spleens
and livers when compared to infected controls, further showing the effcacy of the bone
marrow reconstitution (Table III-S). In 2 experiments, NK cell-depleted B6 129 mice
had 1.2::.2 10glO PFU more virus in the spleen 
(p 
= 0.0002) and 0. 6:!O. 3 10glO PFU more
virus in the liver 
(p 
= 0.0002) compared to NK cell-intact, MCMV-infected controls
(Table 111-2). However, NK cell-depleted IFN- mice showed only an increase in
splenic titers with no appreciable increase of MCMV in the liver (Table III-S). In 4
experiments performed, there was an average I. 5:t0.4 IOglO PFU increase in splenic titers
:''
12:1 25:1 50:1 100:1
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Figure 111-4. NK cell activity from IF- 0/0 and B6 129 mice. Three days post-
infected, spleen cells from MCMV- infected IF- 0/0 control CO), MCMV-infected
anti-NK1.1- treated IF- 0/0 ), MCMV- infected B6 129 control CD), and
MCMV-infected, anti-NK1.1-treated B6 129 (8) mice were used as effectors against
Y AC- 1 targets in a standard 5- Cr release assay.
c;;:
Table II-5. Effects of Anti-NK1.1 mAb Treatment on the Regulation ofMCMV in
B6--IF- 0/0 and B6--129 Mice
Exp
LOg lO PFU/or an + SD
Group Spleen Liver
B6--IF-
-:I.4:t. 8:t.
B6--JF- 0/0 + anti-NKI. 8:t. 6:t.
B6--IF- 0/0
-:1.I:t. 0:t.
B6--IF- 0/0 + anti-NK1.1 6:t. 4.3:tA
B6--IF- 0/0
-:2.S:t.3 4.4:tA
B6--IF- 0/0 + anti-NK1.1 8:t.6:t.
B 6-- IF yR 0/0
-:1.4f:0. 8:t.
B6--IF- OIO + anti-NK1.1 6:t. 9:t.
B6--129 1.3:t. 3.4:t.
B6--129 + anti-NK1.1 8:t.4 1:t.
B6--129
-:1.9:t. 9:t.
B6--129 + anti-NK1.1 9:t. 4.4:t.
a Age matched B6--IF- 0/0 mice or B6--129 mice were infected i.p. with 10 MCMV
PFU/mouse. Anti-NK1.1 was given i.v. 1 day prior to infection.b Spleen and liver MCMV PFU were titrated 
on C57BL/6 MEF 3 days post inection.
C Splenic NK cells were used as effectors against Y AC- l targets. The results are shown 
Figure il -
* NK cell depletion caused a significant increase in virus titers compared to the appropriate
controls, p -: 0. 01.
# NK cell depletion caused a significant increase in virus titers compared to the appropriate
controls, p -: O. OOS.
(p 
= 0.0002) but only a 0.03:1.3 10gIO PFU increase in the livers of NK cell-depleted
IF- 0/0 over the infected untreated controls (Table 111-2). These results are
compatible with the concept that IF- is the NK cell-dependent mechanism that regulates
MCMV synthesis in the liver but not in the spleen. To be certain that the effect seen in the
:;:
spleens ofNKl.I-depleted IF- 0/0 mice was not due to the donor cells ' ability to
respond to IF-
y, 
perf orin bone marrow cells were used to reconstitute IF- 0/0
mice, and the effects of depleting NK 1. 1 + cells in MCMV -infected, perforin O/O IF-
0/0
chimeric mice were measured. Three days post-MCMV infection, NK cell-depleted
perf orin 0/0 IF- 0/0 mice (spleen: 3.2:t0. 2 10gIO PFU; liver: 4. 8:t0. 2 10gIO PFU) had
about the same amount of virus in the spleen and liver when compared to the NK cell-
intact, untreated control (spleen: 3.4:t0. I 10glO PFU; liver: 4.9:1.2 10gIO PFU). This result
fi.
strongly suggests that the early regulation of MCMV in the spleen is controlled by
perforin.
EFFECTS OF AN INOS INIBITOR, L-NM ON THE REPLICATION OF
MCMV IN C57BL/6 MICE
One of the ways IF- can inhibit virus replication is by inducing the expression of
the gene iNOS which encodes nitric oxide synthase (NOS), which in turn catalyzes the
guanidino nitrogen of L-arginine into a free radical gas, nitric oxide (NO) (Nathan, 1992).
NO production by NOS has been shown both in vivo and in vitro to inhibit ectromelia
virus, VV and HSV- I replication (Karupiah et aI. , 1993b; Harris et aI. , 1995). To see if
MCMV is regulated by IF- via the production of NO and to determine if this regulation
is organ-dependent, we treated MCMV -infected mice with a competitive inhibitor of
NOS, L-NM and measured the NK cell activity as well as the viral titers in both spleens
and livers of these mice. Three days post-MCMV infection, L-NMA or its stereoisomer
NM had no effect on the NK cell-mediated lysis (Figure III-S). L-NMA-treated mice
had more virus in the liver compared to the infected controls, but the splenic titers
remained the same in these mice (Table 111-6). The enantiomeric analogue of L-NMA, D-
NM had no effect on the virus titers in either the spleen or the liver (Table 111-6). In 3
experiments, L-NM treatment induced an average of 0. 6::.4 10gIO PFU increase in liver
virus titers 
(p 
= 0.003) but caused a 0. 2:t0.4 10gIO PFU decrease in the spleen compared to
untreated controls (Table 111-2). Compared to the D-NM control, L-NMA-treated mice
had 0. 8::.4 10glO PFU more virus in the liver 
(p 
= 0.0004), but there was no appreciable
difference in splenic MCMV titers (Table 111-2). This suggests that MCMV synthesis in
the liver but not in the spleen is regulated by IFN- induced nitric oxide and adds further
evidence to the concept that the control of MCMV infection is mediated by different
mechanisms in the spleen and liver.
In this chapter, I provided evidence that in the early phase of MCMV infection
NK cells in Cmv- CS7BL/6 mice have the ability to use different mechanisms to control
MCMV in different organs. In the spleen, NK cells may control MCMV via a perf orin-
25:1 50:1 100:1 200:1
EfT RATIO
Figure IIT-S. NK cell activity from L-NM- and D-NM-treated CS7BL/6 mice. Three
days post- infection, spleen cells from urnnfected (0), MCMV-infected (8), MCMV-
infected, anti-NK1.1-treated (D), MCMY -infected, L-NM-treated (8), and MCMV-
infected, D-NM-treated (A) CS7BL/6 mice were used as effectors against Y AC-
targets in a standard 5- Cr release assay.
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dependent cytotoxic mechanism, while in the liver IF- produced by NK cells is a major
mediator in regulating the virus in that organ.
CHAPTER IV
MECHANISMS OF MCMV REGULATION IN SUCKLING MICE BY
ADOPTIVLY TRANSFERRD NK CELLS
Three week old or younger suckling mice are very susceptible to MCMV
infections because NK cells take about 3 weeks from birth to reach maturity (Boos and
Wheelock, 1971; Kiessling et aI., 1975a). Bukowski et al have shown that the adoptive
transfer of syngeneic adult spleen cells into suckling mice prior to MCMV infection can
protect the suckling mice ITom a lethal MCMV infection (Bukowski et aI., 1985).
Analyses of splenic MCMV titers indicated that suckling mice adoptively reconstituted
with adult spleen cells have lower MCMV titers compared to control suckling mice. This
protection is mediated by NK cells as the depletion of NK cells from the adoptively
transferred splenic population abrogated this protection. Splenocytes depleted of T cells
do not confer protection in suckling mice. However, a T cell clone with NK cell-like
activity also protected suckling mice from MCMV (Bukowski et aI., 1985). Taken
together, these results show that suckling mice are good models to study the mechanisms
used by NK cells in the regulation ofMCMV synthesis.
In Chapter In, I have presented evidence that NK cells use a perf orin-dependent
mechansm to control splenic MCMV synthesis in adult C57BL/6 mice. The mechanisms
of protection afforded by the adoptively transferred NK cells in the suckling mouse system
are not known. To examine this, adoptive transfers of C57BL/6, 129 or perf orin % adult
spleen cells and LAK cells into MCMV-infected C57BL/6, 129 or IF- 0/0 suckling mice
were performed. In this chapter, I wil present evidence that unlike the adult mouse
system, adoptively transferred NK cells protect the spleens of suckling mice from MCMV
via an IF- dependent mechanism.
EFFCTS OF ADOPTIVELY TRASFERRD C57BL/6 OR 129 ADULT
SPLEEN CELLS AN LAK CELLS ON THE REGULATION OF MCMV IN
C57BL/6 SUCKLING MICE
Four to six day old C57BL/6 suckling mice were adoptively reconstituted with
C57BL/6 or 129 spleen cells and LAK cells prior to infection, and splenic MCMV titers
were measured 3 days post-infection. As expected, C57BL/6 spleen cells or C57BL/6
LAK cells when transferred into the suckling mice significantly lowered MCMV titers in
the spleen compared to the media controls (Table IV- I). 129 spleen cells when adoptively
transferred into C57BL/6 suckling mice had a protective effect in the spleen compared to
the media controls (Table IV- , Exp 1). Adoptive transfer of 129 LAK cells into C57BL/6
suckling mice also lowered splenic MCMV titers to the levels similar to that mediated by
C57BL/6 LAK cell-reconstituted suckling mice (Table IV- , Exp 2). These results are
surprising in view of the fact that the 129 strain is Cmv- and the regulation of splenic
MCMV in adult C57BL/6 mice is Cmv- dependent (Chapter III, Tay and Welsh, 1997).
Table IV-I. Mechanisms of MCMV Regulation in Adoptively Reconstituted
C57BL/6 Suckling Mice
Exp GrOUp # of cells
Transferred
LOglO PFU MCMV
per Spleen :: SD
value
Media Control I:t.
+ 129 spleen cells 5 x 10 3.4:t. -( 0.
+ C57BL/6 spleen cells 5 x 10 3:t. -( 0.001
Media Control 0:.
+ 129 LAK cel1s 5 x 1 0 3:t. -( 0.001
+ C57BL/6 LAK cells 5 x 1 0 2:t. -( 0. 001
Media Control I:t.
+ Perforin % spleen cel1s 5 x 10 2:t. -( 0. 001
+ C57BL/6 spleen cells 5 x 10 0:t. -( 0.001
Media Control 3.4:t.
+ C57BL/6 spleen cells 5 x 1 0 3.3:t. p=0.
+ Perforin % LAK cells 5 x 10 6:t.4 -( 0.005
+ C57BL/6 LAK cells 5 x 10 5:t. -( 0. 001
Media Control 6:t.2
+ Perforin % LAK cells 5 x 10 I:t.4 p= 0.
+ C57BL/6 LAK cells 5 x 10 2::0. -( 0.
a Four to six day old C57BL/6 suckling mice were given i.p. 2000 PFU MCMV per
mouse.b Age-matched C57BL/6 mice were given 0. 1 ml complete RPMImouse (Media control)
or were adoptively reconstituted i.p. with spleen cells or LAK cells in 0. 1 ml complete
RPMI at the cell concentration shown in the table. All these transfers were perfonned one
day prior to infection.
C Splenic MCMV PFU were titrated on C57BL/6 :MF 3 days after infection.
values were generated by comparing the virus titers from adoptively reconstituted
groups to the media control.
These data therefore suggest that at 3 days post-MCMV infection, the protection afforded
by adoptively transferred NK cells in the spleens of C57BL/6 suckling mice is not Cmv-
dependent.
EFFECTS OF ADOPTIVELY TRASFERRD C57BL/6 OR PERF ORI 0/0
MICE ADULT SPLEEN CELLS AN LAK CELLS ON THE REGULATION
OF MCMV IN C57BL/6 SUCKLING MICE
In adult mice Cmv- dependent NK cell regulation of MCMV in the spleen is
mediated by a perf orin-dependent mechanism (Chapter III, Tay and Welsh, 1997). The
results presented above suggested that the regulation of MCMV in the spleen of the
suckling mouse model was not Cmv- dependent but the role of perforin was not
evaluated. To test the role of perf orin in the regulation of MCMV in suckling mice
perf orin % spleen cells and perforin % LAK cells were adoptively transferred, and their
abilities to control MCMV synthesis in the spleens ofC57BL/6 suckling mice were tested.
Perforin % spleen cells or LAK cells when adoptively transferred into 4 - 6 day
old C57BL/6 suckling mice significantly lowered MCMV titers in the spleens compared to
control spleens (Table IV- , Exp 3 - 5). The levels of protection afforded by perf orin 0/0
spleen cells and LAK cells were similar to that of C57BL/6 spleen cells and C57BL/6
LAK cells respectively. Results presented in Table IV therefore suggest that adoptively
transferred spleen cells or LAK cells protect C57BL/6 suckling mice from MCMV via a
Cmv- independent perf orin-independent mechanism.
EFFCTS OF ADOPTIVEL Y TRASFERRD C57BL/6 SPLEEN CELLS ON
THE REGULATION OF MCMV IN 129 AN IF- 0/0 MICE
In the above experiments, the results show that adoptively transferred NK cells do
not protect the spleens of MCMV -infected suckling mice via perf orin. As NK cells can
regulate MCMV via the production of anti-viral cytokines, one possibility is that the
transferred NK cells control splenic MCMV titers in the suckling mice via the production
of IF-
y. 
To test this, adult C57BL/6 spleen cells were adoptively transferred into 4 - 6
day old 129 or IF- 0/0 suckling mice, and their abilties to reduce MCMV synthesis in
the spleens were measured.
Adult C57BL/6 spleen cells when adoptively transferred into MCMV-infected 129
suckling mice significantly reduced splenic MCMV titers compared to infected control
spleens (Table IV- , Exp 1 and 2). However, the same C57BL/6 spleen cells had no effect
on MCMV splenic titers in MCMV- infected IFN- 0/0 suckling mice. These data suggest
that the control of MCMV synthesis in suckling mice by adoptively transferred cells is
IF - dependent.
Taken together, the results presented in this chapter strongly suggest, that unlike
the adult mouse/MCMV system, the regulation of MCMV in the spleens of suckling mice
by adoptively transferred NK cells is Cmv- independent and perf orin- independent but is
instead IF- dependent.
Table IV-2. Mechanisms of MCl\rV Regulation in Adoptively Reconstituted 129
and IF-yROIO Mice
Exp GrOUp LOglO PFU MCMV /Spleen value
MCMV-infected 129
+ Media 0:1.
+ CS7BL/6 spleen cells S:1. pO: 0. 001
MCMV- infected IF- 0/0
+ Media 3.2:1.
+ CS7BL/6 spleen cells 3:1. = O.
MCMV-infected 129
+ Media 0:1.
+ CS7BL/6 spleen cells 1. 7:1.4 pO: 0. 001
MCMV- infected IF- 0/0
+ Media 9:1.
+ C57BL/6 spleen cells 9:1. p=0.
a Four to six day old 129 
and IF- 0/0 suckling mice were given i.p. 2000 MCMV PFU
per mouse.b One day prior to infection
, suckling mice were either given i. p. 0. 1 ml complete RPMI
per mouse or S x 10 CS7BL/6 spleen cells per mouse.C Splenic MCMV PFU were titrated on C57BL/6 :MF 3 days post infection.
value is calculated by comparing the MCMV titers between the adoptively
reconstituted suckling mice to the media control withi the same experiment.
CHAPTER V
THE ROLE OF LY49 NK CELL RECEPTORS IN THE REGULATION OF
MCMV
In Chapter III, I have provided evidence that in adult C57BL/6 mice, NK cells
used different mechanisms to regulate MCMV synthesis in different organs. The presence
of the innate resistance gene Cmv- dictates that in C57BL/6 mice, the regulation of
MCMV in the spleen is perf orin-dependent while the control of MCMV in the liver 
IF- dependent. Investigators working on the identification of the Cmv- gene product
have indicated that Cmv- is closely linked to the Ly49 receptor family, suggesting that
Cmv- may be an existing or undefined member of the Ly49 multigene family. Since Cmv-
1 is closely linked to the Ly49 family and may also be a possible member, it is possible that
its gene product, like the rest of the Ly49 family members, be differentially expressed in
the various subsets ofNK cells. These different subsets ofNK cells may then use different
mechanisms to control MCMV in different organs. Subsets of NK cells that traffc to the
liver may use an IF- dependent mechanism to control MCMV therein, while the subsets
of NK cells that remain or traffc to the spleen may predominantly use a perforin-
dependent mechanism.
In an effort to understand the roles played by Ly49 NK cell receptors in the
regulation of MCMV, I wil present experiments in this chapter looking at a) the
distribution of Ly49 NK cell receptors in the spleens and peritoneal cavity of uninfected
and 3 day MCMV-infected C57BL/6 mice, b) the regulation ofMCMV infections in adult
C57BL/6 mice treated with mAbs to the different members of the Ly49 family, and c) the
control of MCMV in C57BL/6 suckling mice adoptively reconstituted with various Ly49
LAK cells.
DISTRUTION OF NKI. I + L Y49+ NK CELL SUBSETS IN THE SPLEENS
OF UNECTED AN 3 DAY MCMV -INECTED C57BL/6 MICE
To examine if there were any differences in the distribution of the NK cell subsets
before and after MCMV infection, spleen cells from uninfected and 3 day MCMV -infected
C57BL/6 mice were stained for NKl.I , Ly49A, C, D and G2 NK cell receptors. Three
days post-MCMV infection, the number of spleen leukocytes in MCMV -infected mice was
similar to that in uninfected mice (data not shown). However, FACs analyses based on 10
gated lymphocytes showed that there were fewer NK 1. 1 + cells (2 -3 fold decrease) in the
spleens of MCMV -infected mice compared to that in uninfected mice (Figure V- , Table
I). Analyses of the Ly49 NK cell subset distribution within the NK1.1 + population
before and after MCMV infection revealed that there were increases in the percentages of
NKl.I Ly49A+ and NKl.I Ly49G2+ NK cell subsets and decreases in the percentages
of NKl.I Ly49C+ and NKl.I Ly49D+ NK cell subsets (Table V-2). These results
suggest that, compared to uninfected mice, 3 day MCMV infection of C57BL/6 mice
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Figure V- l. Distribution ofNKl.I Ly49+ NK cells in uninfected and 3 day MCMV-inected
C57BL/6 spleen cells. Spleen cells were staed with anti-NKl.I mAb (y-axs) and anti-Ly49A
(A, E), anti-Ly49C (B, F), anti-Ly49D (C, G) and anti-Ly49G2 (D, II mAbs (x-axs). Data
ITom these FACs profies are reported in Table V- , Exp 1.
Ta
bl
e 
V-
I. 
Fr
eq
ue
nc
y 
of
 N
K
I.l
+
 C
el
ls 
in
 th
e 
Sp
le
en
s 
an
d 
th
e 
Pe
rit
on
ea
l C
av
itie
s 
o
f U
n 
in
fe
ct
ed
, M
CM
V
-I
nf
ec
te
d 
an
d
LC
M
V
 -I
nf
ec
te
d 
C5
7B
L/
6 
M
ice
Sp
le
en
Pe
rit
on
ea
l C
av
itl
N
K
I.
I +
 c
el
ls
p
e
r
 
10
ly
m
ph
oc
yt
es
v
al
ue
N
K
I.
I +
 c
el
ls
p
e
r
 
10
ly
m
ph
oc
yt
es
v
al
ue
Ex
p 
U
ni
nf
ec
te
d
28
5:
t3
30
7:
t3
3
M
CM
V
 -i
nf
ec
te
d
1 
0 
1:
18
-
( 0
.0
01
12
8I
:t6
8
-
( 0
.0
01
LC
M
V
 -i
nf
ec
te
d
29
4:
t0
p=
0.
82
8:
15
6
-
( 0
.0
01
E
x
p
 
2
U
 
n
in
fe
ct
ed
34
9:
13
8
55
9:
11
34
M
CM
V
 -i
nf
ec
te
d
10
8:
16
-
( 0
.0
01
94
7:
t8
6
p
'
 
0.
00
1
LC
M
V
 -i
nf
ec
te
d
28
3:
19
-
( 
0.
38
3:
10
,
 
0.
E
x
p
 
3
U
ni
nf
ec
te
d
34
1:
t5
1
24
6:
t4
6
M
CM
V
 -i
nf
ec
te
d
49
:t9
 
,
0.
00
1
59
8:
13
6
p
'
 
0.
00
1
Ex
p4
U
ni
nf
ec
te
d
88
:t2
 
24
5:
t4
7
LC
M
V
 -i
nf
ec
te
d
15
5:
t9
-
( 0
.
26
7:
17
4
p=
0.
a
 A
ge
-m
at
ch
ed
 C
57
BL
/6
 m
ice
 w
er
e 
ei
th
er
 u
ni
nf
ec
te
d 
or
 g
ive
n 
i. p
.
 
1 
x 
10
PF
U
/M
CM
V
 p
er
 m
ou
se
 o
r 5
 x
 1
0
PF
U
/L
CM
V
 p
er
m
o
u
se
.
Sp
le
en
 c
el
ls 
an
d 
pe
rit
on
ea
l c
av
ity
 c
el
ls 
we
re
 re
m
ov
ed
 fr
om
 u
ni
nf
ec
te
d,
 
3 
da
y 
M
CM
V-
in
fe
ct
ed
 o
r 3
 d
ay
 L
CM
V-
in
fe
ct
ed
C5
7B
L/
6 
m
ic
e a
nd
 st
ai
ne
d 
w
ith
 an
ti-
N
K
1.
1-
PE
 m
A
b.
 A
 ly
m
ph
 g
at
e 
w
as
 u
se
d 
to
 a
na
ly
ze
 th
e 
ce
lls
.
C 
Th
e 
nu
m
be
r o
fN
K
1.
1 +
 c
e
lls
 w
as
 b
as
ed
 o
n 
10
ly
m
ph
oc
yt
es
.
va
lu
e 
is
 c
al
cu
la
te
d 
by
 c
om
pa
rin
g 
th
e 
nu
m
be
r o
f N
K 
1.
1 
+ 
ce
lls
 fr
om
 in
fe
ct
ed
 m
ice
 to
 th
e 
nu
m
be
r o
f N
K 
1.
1 
+ 
ce
lls
 in
 th
e
u
n
in
fe
ct
ed
 c
on
tro
ls 
w
ith
in
 th
e 
sa
m
e 
ex
pe
rim
en
t.
Ta
bl
e 
V-
2.
 E
xp
re
ss
io
n 
of
 N
K1
.1
 a
nd
 L
y4
9 
R
ec
ep
to
rs
 in
 U
ni
nf
ec
te
d,
 M
CM
V
-I
nf
ec
te
d 
an
d 
LC
M
V
-I
n
fe
ct
ed
 s
pl
en
oc
yt
es
o
f C
57
BL
/6
 M
ic
e
G
ro
up
N
K
1.
I
Ly
49
- 
(R
lt 
pe
r
N
K
1.
I
Ly
49
(R
2t 
pe
r
(R
2/
(R
l+
R2
))
 x
 I
OO
R
el
at
iv
e 
ch
an
ge
ly
m
ph
oc
yt
es
ly
m
ph
oc
yt
es
co
m
pa
re
d 
to
 u
ni
nf
ec
te
d
co
n
tr
ol
Ex
p 
1:
D
a
y
 
0 
N
K
l.I
-L
y4
9A
22
2
15
%
N
K
l.I
-L
y4
9C
18
6
13
0
41
%
N
K
l.I
-L
y4
9D
15
8
12
8
45
%
N
K
l.I
-L
y4
9G
2
17
2
11
1
39
%
D
ay
 3
 M
CM
V
N
K
l.I
-L
y4
9A
17
%
In
cr
ea
se
N
K
l.I
-L
y4
9C
23
%
D
ec
re
as
e
N
K
l.I
-L
y4
9D
40
%
D
ec
re
as
e
N
K
l.I
-L
y4
9G
2
54
%
In
cr
ea
se
D
ay
 3
 L
CM
V
N
K
l.I
-L
y4
9A
20
8
24
%
In
cr
ea
se
N
K
l.
Ly
49
C
18
4
10
7
37
%
D
ec
re
as
e
N
K
l.I
-L
y4
9D
16
8
15
4
48
%
D
ec
re
as
e
N
K
l.I
-L
y4
9G
2
10
9
18
0
62
%
In
cr
ea
se
Ex
p 
2:
D
a
y
 
0
N
K
I.
Ly
49
A
26
1
19
%
N
K
l.
Ly
49
C
24
2
16
1
40
%
N
K
l.I
-L
y4
9D
20
3
15
0
42
%
N
K
l.I
-L
y4
9G
2
18
3
13
7
43
%
D
ay
 3
 M
CM
V
N
K
l.I
-L
y4
9A
25
%
In
cr
ea
se
N
K
1.
1-
Ly
49
C
16
%
D
ec
re
as
e
N
K
l.l
-L
y4
9D
29
%
D
ec
re
as
e
N
K
l.I
-L
y4
9G
2
55
%
In
cr
ea
se
D
ay
 3
 L
CM
V
N
K
l.I
-L
y4
9A
23
1 
.
21
%
In
cr
ea
se
N
K
1.
I-
Ly
49
C
16
5
10
9
40
%
N
o 
ch
an
ge
N
K
1.
I-
Ly
49
D
14
1
13
6
49
%
In
cr
ea
se
N
K
l.I
-L
y4
9G
2
12
1
16
7
58
%
In
cr
ea
se
Ex
p 
3:
D
a
y
 
0 
N
K
1.
Ly
49
A
25
9
17
%
N
K
1.
I-
Ly
49
C
15
2
14
2
48
%
N
K
1.
Ly
49
D
16
0
25
1
61
%
N
K
1.
1-
Ly
49
G
2
14
8
20
0
57
%
D
ay
 3
 M
CM
V
N
K
1.
I-
Ly
49
A
51
%
In
cr
ea
se
N
K
1.
I-
Ly
49
C
30
%
D
ec
re
as
e
N
K
I.
Ly
49
D
45
%
D
ec
re
as
e
N
K
1.
I-
Ly
49
G
2
12
5
70
%
In
cr
ea
se
D
ay
 3
 M
CM
V
*
N
K
1.
I-
Ly
49
A
60
%
In
cr
ea
se
N
K
1.
I-
Ly
49
C
43
%
D
ec
re
as
e
N
K
I.
Ly
49
D
49
%
D
ec
re
as
e
N
K
1.
I-
Ly
49
G
2
14
0
80
%
In
cr
ea
se
Ex
p 
4:
D
a
y
 
0 N
K
1.
1-
Ly
49
A
N
K
1.
1-
Ly
49
C
N
K
1.
1-
Ly
49
D
N
K
1.
I-
Ly
49
G
2
15
0
11
8
11
5
10
1
18
%
43
%
43
%
36
%
D
ay
 3
 M
CM
V
*
N
K
1.
I-
Ly
49
A
N
K
1.
1-
Ly
49
C
N
K
1.
1-
Ly
49
D
N
K
1.
1-
Ly
49
G
2
21
%
23
%
36
%
In
cr
ea
se
D
ec
re
as
e
D
ec
re
as
e
N
o 
ch
an
ge
D
ay
 3
 L
CM
V
N
K
1.
1-
Ly
49
A
N
K
l.
Ly
49
C
N
K
1.
1-
Ly
49
D
N
K
1.
1-
Ly
49
G
2
16
4
15
%
30
%
41
%
58
%
D
ec
re
as
e
D
ec
re
as
e
D
ec
re
as
e
In
cr
ea
se
a
 A
ge
-m
at
ch
ed
 C
57
BL
/6
 m
ice
 w
er
e 
gi
ve
n 
i.p
.
 
1 
x 
10
PF
U
 M
CM
V
 p
er
 m
ou
se
,
 
2 
x 
10
PF
U
 M
CM
V
 p
er
 m
ou
se
 (*
), o
r 5
 x 
10
PF
U
 L
CM
V
 p
er
 m
ou
se
.
b 
Sp
le
en
 c
el
ls 
we
re
 re
m
ov
ed
 fr
om
 u
ni
nf
ec
te
d ,
 
3 
da
y 
M
CM
V
-in
fe
ct
ed
 o
r 3
 d
ay
 L
CM
V
- in
fe
ct
ed
 C
57
BL
/6
 m
ic
e a
nd
 st
ai
ne
d 
w
ith
an
ti-
N
K
1.
1-
PE
 m
A
b 
an
d 
an
ti-
Ly
49
A
-F
IT
C
,
 
-
Ly
49
C-
FI
TC
,
 
-
Ly
49
D
- F
IT
C 
or
 -L
y4
9G
2-
FI
TC
 m
A
bs
. A
 ly
m
ph
 g
at
e 
w
as
 u
se
d 
to
a
n
a
lyz
e 
th
e 
ce
lls
.
C 
RI
 a
nd
 R
2 
ga
te
s w
er
e 
dr
aw
n 
ar
ou
nd
 N
K
I.
I +
 -L
y4
9-
 an
d 
N
K
I.
I +
 -L
y4
9+
 c
el
ls 
re
sp
ec
tiv
el
y,
 in
 th
e 
F 
A
Cs
 p
ro
fil
es
. A
n 
ex
am
pl
e 
th
is
 c
an
 b
e 
se
en
 in
 F
ig
ur
e 
V 
-2
. T
he
 n
um
be
rs
 re
fle
ct
ed
 in
 e
ac
h 
co
lu
m
n 
ar
e 
th
e 
nu
m
be
r o
f p
os
iti
ve
 e
ve
nt
s p
er
 1
0
ly
m
ph
oc
yt
es
.
d 
Th
is 
pe
rc
en
ta
ge
 re
fle
ct
s t
he
 n
um
be
r o
fN
K
I.
I +
 c
el
ls
 th
at
 s
ta
in
ed
 p
os
iti
ve
 fo
r r
es
pe
ct
iv
e 
Ly
49
 N
K
 ce
ll 
re
ce
pt
or
s.
resulted in a decrease in the number of NK 1. 1 + cells per 10 lymphocytes and changes in
the percentages ofNKI. I + -Ly49+ NK cell subsets within the spleen.
DISTRUTION OF NK 1. 1 + -L Y 49+ NK CELL SUBSETS IN THE
PERITONEAL CAVITY OF UNINECTED AN 3 DAY MCMV -INECTED
C57BL/6 MICE
Analyses of the NK 1.1 + -Ly49+ NK cell subsets in the spleen indicated that even
though the absolute number of splenocytes was similar between uninfected and infected
mice, F ACS analyses based on 10 lymphocytes showed that there were decreases in the
number of NK 1. 1 + cells, and changes in the proportion of the NKl.I Ly49+ subsets after
MCMV infection. To examine if there were any changes in the NK cell population in the
peritoneal cavity, peritoneal exudate cells (PEC) from uninfected and 3 day MCMV-
infected C57BL/6 mice were stained with antibodies to NKl.I , Ly49A, C, D and G2 NK
cell receptors. Compared to the uninfected controls, there was usually about a 2 fold
increase in the absolute number ofPEC in MCMV-infected mice (data not shown). FACs
analyses showed that there were significantly more NK 1. 1 + cells per 10 lymphocytes (2 -
4 fold increase) in the peritoneal cavity of3 day MCMV-infected mice (Table V- , Figure
V -2). These data suggest that either there is an influx of NK1.1 + cells into the peritoneal
cavity during MCMV infection or else the resident NK cells are proliferating. Three days
post-MCMV infection, FACs analyses of the Ly49 NK cell subsets within the NK1.I
population showed that there was a decrease in the percentage of NK1.1 + Ly49A+ cells
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Figure V-2. Distribution ofNKI. Ly49+ NK cells in uninfected and 3 day MCMV-infected
C57BL/6 peritoneal exudate cells (PECs). PECs were staied with anti-NK1.1 mAb (y-axs)
and anti-Ly49A (A, E), anti-Ly49C (B, F), anti-Ly49C (C, G), or anti-Ly49G2 (D, II mAbs
(x-axs). Data ITom these FACs profies are reported in Table V- , Exp 1.
while there were increases in the percentages of NK1.I Ly49C+, NKl.I Ly49D+ and
NK1.I Ly49G2+ cells (Table V-3).
Results ITom Tables V-2 and V-3 indicated that 3 days post-MCMV infection
there was within the NK1.I + population an increase in the percentage ofNK1.I Ly49A
cells while there were decreases in the percentages of NKl.I Ly49C+ and NKl.I
Ly49D+ cells in the spleen. This was accompanied by the concomitant decrease in the
percentage ofNKl.I Ly49A+ PECs and increase in the percentage of NK1.I Ly49C+
and NKl.I Ly49D+ PEC. In both the spleen and the peritoneal cavity, the percentage of
NK1.I Ly49G2+ cells increased after MCMV infection. These results strongly suggest
that 3 days post-MCMV infection, there was movement ofNKl.I Ly49+ NK cell subsets
in the spleen and the peritoneal cavity. A summary of the results is shown in Figure V -
DISTRIUTION OF NKI. I + -L Y 49+ NK CELLS IN THE SPLEEN 
PERITONEAL CAVITY IN UNINECTED AN 3 DAY LCMV -INECTED
C57BL/6 MICE
To determne if the above mentioned pattern of NK cell traffcking only occurred
during MCMV infection, C57BL/6 mice were infected with a different virus, LCMV, and
spleen cells and PEC were then stained with the various NK cell receptor antibodies.
There were few differences in the absolute number of splenic leukocytes and PEC ITom 3
day LCMV-infected mice compared to uninfected mice (data not shown). FACs analyses
also showed that there were few differences in the number of NKI. I + cells in the spleen
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(Table V- I), and in only lout of 3 experiments, there was an increase in NK 1.1 + cells per
lymphocytes in the peritoneal cavity (Table V- I). The distribution of the various Ly49
NK cell receptors in the spleen and the peritoneal cavity did not follow a reproducible
pattern after 3 days ofLCMV infection (Table V- , Table V- , Figure V-4). There were
little to no changes in the percentages of NK1. I Ly49A+, NK1.I Ly49C+ and NKl.I
Ly49D+ cells in the spleen while the changes in the percentage of these 3 (A, C, and D)
Ly49 NK cell subsets were at best erratic in the peritoneal cavity. There was, however, an
increase in the percentage ofLy49G2+ NK cell subset in both the spleen and the peritoneal
cavity (Table V- , Table V- , Figure V-4). Thus, the distribution of Ly49 NK cell subsets
after MCMV infection is distinct for that particular virus infection, thereby suggesting that
the Ly49 NK cell subsets may playa role in the regulation ofMCMV in C57BL/6 mice.
EFFECTS OF IN VIVO ANTI-LY49 MAB TREATMNT ON THE
REGULATION OF MCMV IN C57BL/6 MICE
Three days post-MCMV infection, there was a shift in the percentages of Ly49
NK cell subsets in the spleen and peritoneal cavity, suggesting that there was traffcking of
the different Ly49 subsets to different locations after MCMV infection. To examine the
importance of the different Ly49 subsets in the early regulation of MCMV, one of the
known Ly49 subsets or a combination of Ly49 subsets were depleted with mAbs, and NK
cell activity and MCMV titers in the spleen and the liver were then measured. The anti-
Ly49C and anti-Ly49G2 Abs were previously titrated in vivo by our collaborators (Drs.
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V. Kumar and J.R. Ortaldo) by measuring the rejection of parental bone marrow cells by
Ly49C+ and Ly49G2+ cells in FI (b x d) mice. Anti-Ly49A and anti-Ly49D Abs were also
previously titrated in vivo by our collaborators to ensure that the correct doses were used
to in vivo deplete the respective Ly49 NK cell subsets. Depletion of a single Ly49 NK cell
subset (Ly49A, Ly49C, Ly49D or Ly49G2 alone) had very little effect on NK cell
cytotoxicity compared to MCMV -infected mice treated with anti-NK 1. 1 mAb (Figure V-
A, B and C). When compared to the infected controls, 3 day MCMV -infected CS7BL/6
mice treated with either anti-Ly49A, C, D or G2 mAbs alone exhbited no increase in virus
titers in the spleen and the liver (Table V - , Exps 1 - S). Depletion of 2 subsets of Ly49
NK cells (Ly49C and Ly49D, Ly49C and Ly49G2 , Ly49D and Ly49G2) had some effect
on NK cell cytotoxicity (Figure V -S D and E), but these depletions had no effect on the
regulation ofMCMV in the spleen and the liver (Table V- , Exps 6 and 7). In 2 separate
experiments, depletion of 3 Ly49+ NK cell subsets (Ly49C, Ly49D and Ly49G2) resulted
in diminished NK cell activity (Figure V -S) but in only 1 experiment did such a depletion
resulted in the increase ofMCMV titers in the spleen and the liver (Table V- , Exps 7 and
8). As a positive control in all the experiments, C57BL/6 mice treated with anti-NK1.1
mAb to deplete the NK cells exhibited the expected increase in MCMV titers in the spleen
and the liver. These results suggest that in adult CS7BL/6 mice the absence of anyone
particular Ly49 NK cell subset does not affect the ability of the residual NK cells to
control MCMV.
50 0 12:1 25:1 50:1100:1
12:1 25:1 50:1100:1
40 0 25: 1 50: 1 100: 1200: 1
12:1 25:1 50:1100:1
12:1 25:1 50:1100:1 12:1 25:1 50:1100:1
EfT RATIO
Figure V-So NK cell activity from C57BL/6 mice treated with anti-Ly49 Abs. Three days
post-infection, spleen cells ITom MCMV-inected (A - F, 0), MCMV-infected, anti-
NKl.I-treated (A - F 8), anti-Ly49A-treated (A, D), anti-Ly49C-treated (B , D), anti-
Ly49D-treated (C D), anti-Ly49G2-treated (C 8), anti-Ly49C-
, -
Ly49D-treated (D II),
anti-Ly49C-
, -
Ly49G2-treated (D, D), anti-Ly49D-
, -
Ly49G2-treated (E, D), anti-
Ly49C-
, -
Ly49D-
, -
Ly49G2-treated (E, 8), and anti-Ly49C-
, -
Ly49D-
, -
Ly49G2-treated
(F, D) C57BL/6 mice were used as effectors against Y AC- l targets in a standard 5-
Cr release assay.
Table V- 4. Effects of in vivo Anti-Ly49 mAb Treatment on the Replication of
MCMV in C57BU6 Mice
Exp
LOg lO PFU/Or an + SDSpleen LiverGroup
MCMV -infected Control -:2A:t. 4A:t.
MCMV -infected + anti-NK 1. 9:t. 8:t.
MCMV-infected + anti-Ly49A -:2A:t. I c 3:t. I f
MCMV -infected Control
-:2.3:t. -:3.3:t.
MCMV - infected + anti-NK 1.1 3A:t. 3:t. l d
MCMV - infected + anti-Ly49C -:2A:l0. 1 f 3A:l0.
MCMV - infected Control 7:t. 2:t.2
MCMV-inected + anti-NK1.1 2:10A 5:t. I d
MCMV - infected + anti-Ly49C 8:10 . o:t.
MCMV -infected Control 2A:t. 2:10.
MCMV- infected + anti-NK1.1 0:t. l c 8:10.
MCMV -infected + anti-Ly49C 5:10. 3:t.
MCMV -infected Control -:I.3:t. 3A:tA
MCMV-infected + anti-NKI. 6:10. 7 1:10. 
MCMV-infected + anti-Ly49D 5:t. 6:t.
MCMV -infected + anti-Ly49G2 1. 6:t. 7 8:!.
MCMV -infected Control 5:10. 1:t.
MCMV-infected + anti-NK1.1 1:10. 1 c 8:10.2
MCMV - infected + anti-Ly49C + anti-Ly49D 9:10. 3:1.2
MCMV-infected + anti-Ly49C + anti-Ly49G2 6:1.2 2:10.2
MCMV -infected Control 1. 6:10. A:t0.
MCMV-infected + anti-NK1.1 5:10. 1 c 6:10. 1 c
MCMV-infected + anti-Ly49D + anti-Ly49G2 1. 6:10. 3A:l0.
MCMV- infected + anti-Ly49C + anti-Ly49D 1.5:1. 3 .9:1 . 0 1 f
+ anti-Ly49G2
, l
100
MCMV-infected Control
MCMV-infected + anti-NKI.
MCMV- infected + anti-Ly49C + anti-Ly49D
+ anti-Ly49G2
3:t.3
9:t.
3:t0
1.5:1.
7:t.
5:t0.3
a Age-matched CS7BL/6 mice were infected i.p. with 10 MCMV PFU per mouse. Anti-
NK1.I , anti-Ly49A, anti-Ly49C and anti-Ly49G2 were given i.v. 1 day prior to infection.
Anti-Ly49D was given i. , at day -2 and day -1 prior to infection. b Splenic and Liver MCMV PFU were titrated on CS7BL/6 MEF 3 days post-infection.C Compared to the infected control
, anti-NK cell treatment resulted in a p .: O.OOS.d Compared to the infected control
, anti-NK cell treatment resulted in a p': O. OS.
e Compared to the infected control
, anti-NK cell treatment resulted in a p:: O.
f Compared to the infected control
, anti-NK cell treatment resulted in a p
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EFFECTS OF ADOPTIVEL Y TRASFERRD L Y 49+ LAK CELLS ON THE
REGULATION OF MCMV IN SUCKLING MICE
To further clarify the role of Ly49 NK cell receptors in the regulation of MCMV
by NK cells, we tested the abilty of NK1.1 +, Ly49+ LAK cells to protect suckling mice
from a lethal MCMV infection. LAK cells were generated using 6 - 12 week old CS7BL/6
spleen cells. Figure V -6 shows the typical distribution of the different Ly49 subsets within
the NKI. + LAK cell population. The percentages of the different Ly49 NK cell subsets in
the LAK cell cultures are similar to the percentages seen in spleen NK cells taken ITom
naive CS7BL/6 mice (Table V -2). Prior to adoptive transfers, the LAK cells were sorted
into NK1.I Ly49- or NKl.I Ly49+ for all the 4 Ly49 subsets (A, C, D, G2). These
sorted LAK cells were adoptively transferred into 4 - 6 day old CS7BL/6 suckling mice
which were subsequently infected with MCMV, and splenic MCMV titers were measured
3 days later. Suckling mice adoptively reconstituted with any of the different combinations
of NKI. I + LAK cells had lower splenic MCMV titers compared to the media control
(Table V-S). For example, both NK1.I Ly49A LAK cells and NK1.I Ly49A+ LAK cells
significantly decrease the amount of MCMV in the spleen of the suckling mice compared
to the media control (Table V - , Exp 2). These results suggest that the presence or
absence of anyone of the Ly49 NK cell receptors does not have an effect on NK cell'
abilty to protect suckling mice ITom MCMV.
- -,;:
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Figure V-6. FACs profiles ofLAK cells. LAK cells stained with anti-NK1.I-PE mAbs (y-
axs) and anti-Ly49A-FITC
, -
Ly49C-FITC
, -
Ly49D-FITC, or -Ly49G2-FITC (x-axis).
LAK cells were generated ITom nylon-wool-passaged naive C57BL/6 spleen cells treated
with 800 U/ml IL-2 for 7 - 9 days. LAK cultures are 96% - 99% NK 1.1 + . Ly49 A + cells
make up 15%; Ly49C+, 30%; Ly49D , 54%; and Ly49G2 , 57% of all NKl.I + cells.
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Taken together, these results strongly suggest that a single Ly49 NK cell receptor
Ly49A, C, D or G2 does not play an essential role in the control ofMCMV synthesis by
NK cells in both adult and suckling mice.
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CHAPTER VI
NK CELL RESPONSE TO VIL INFECTIONS IN Jh-MICROGLOBULIN-
DEFICIENT MICE.
Sensitivity of target cells to lysis by NK cells is inversely proportional to the
amount of MHC class I expressed on the cell surfaces of the target cells (Missing Self
Hypothesis), and in vitro studies have indicated that the interaction between most murine
NK cell receptors and MHC class I molecules are inhbitory on the NK cells. As some
viruses e.g. MCMV, have the abilty to downregulate class I molecules, this virus-induced
downegulation of MHC class I on infected cells could sensitize the infected cells to NK
cell cytotoxicity by removing the inhbitory signaVs sent to the NK cells. We have shown
that during a virus infection in vivo the IF response (and possibly other cytokines)
causes a major up-regulation of MHC class I molecules throughout the body, and the
uninfected cells in the host become more resistant to NK cells as they become substantially
more susceptible to lysis by allospecific CTL (Hansson et aI. , 1980; Bukowski and Welsh
1986). It is possible that NK cells may fail to regulate the LCMV infection because IF
via the up-regulation of class I antigens, protects the LCMV -infected targets ITom NK
cells; in contrast, NK cells may regulate MCMV infection because IFN cannot protect the
MCMV -infected targets, as the virus downregulates MHC class I expression and 
.. Work performed in this chapter was done in collaboration with Dr. R. R. Brutkiewicz (Tay et aI. , 1995).
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cannot induce the levels ofMHC class I on infected cells (Bukowski and Welsh, 1985b).
In both cases, uninfected target cells would be spared the lytic effects ofNK cells, because
these normal cells would also be protected by IF ITom NK cells. To understand the
importance of class I antigens in the regulation of viral inections by NK cells, I examined
viral infections in mice whose pzm gene has been deleted by homologous recombination
(Koller et aI., 1990). Cells ITom these pzm (-/-) mice do not express class I a-chain
detectable by conformation-dependent Abs on their plasma membranes, although some
reports suggest that there are some conformationally normal class I molecules present in
low amounts (Bix and Raulet, 1992; Glas et aI., 1992a). These mice have low levels of
endogenous NK cell activity, but it can be augmented by treatment with the IF inducer
poly I:C (Hoglund et aI. , 199Ib; Liao et aI. , 1991). Spleen lymphocytes of pzm (-/-) mice
when stimulated by Con A, are highly sensitive to lysis by normal pzm intact mouse NK
cells, which preferentially lyse targets low in class I MHC expression. These targets are
much less sensitive to pzm (-/-) NK cells.
In this chapter, I wil present evidence showing that, despite their inability to
express MHC class I molecules in the correct conformation, and despite the resistance of
these cells to IF-mediated protection against NK cells, pzm (-/-) mice stil retain the
ability to control MCMV.
I:'
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ACTIVATION OF NK CELLS IN VIUS-INECTED MICE
C57BL/6 and J32m /-) mice, either PBS-treated or depleted of NK cells with
antiserum to aGMI, were inected i.p. with MCMV (Figure VI- I A, B) or LCMV (Figure VI-
, D) and tested 3 days later for spleen NK cell activity. Figure VI-I (A, B) shows
representative experients indicating that the inection of either C57BL/6 or J32m /-) mice
with MCMV elicited an augmentation ofNK cell activity compared to the uninfected controls.
The levels ofNK cell activity in the uninfeced J32m /-) mice were quite low confg the
work of others (Hoglund et al. , 1991; Liao et al. , 1991). Admistration of antiserum to aGM
signcantly reduced the NK cell aqivity in the MCMV-ineced C57BL/6 or J32m /-) mice.
Figure VI- I (C, D) also shows that LCMV induced a more profound NK cell activation in both
C57BL/6 and J32m /-) mice, and, agai the NK cell response was completely ablated by
antiserum to aGM
REPLICATION OF MCMV IN NK CELL-DEPLETED M (-/-) MICE
Replication ofMCMV was, in several experients, markedly elevated in the NK cell-
depleted C57BL/6 mice, confrmng earlier reports (Bukowski et al., 1983; Bukowski and
Welsh, 1985b; Bukowski et al. , 1985; Table VI- I). The sythesis ofMCMV was comparable
in the J32m /-) and the C57BL/6 mice, and depletion ofNK cells with antiserum to aGMI, as
with the C57BL/6 mice, resulted in substantialy higher levels ofMCMV synthesis in the J32m 
C57BU6 m (-
/-)
6:1 12:1 25:1 50:1 6:1 12:1 25:1 50:1
C57BU6 m (-
/-)
6:1 12:1 25:1 50:1 6:1 12:1 25:1 50:1
Err RATIO
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Figure VI-I. NK cell activity ITom C57BL/6 (+/+) and 2m (-/-) mice. NK cells from
uniected (0), vis-inected (8) and virus-infected and anti-asialo GM1-treated (D) mice
were used as effectors agaist Y AC- 1 targets in a standard 4 h Cr release assay. Three days
before the assay, mice were infected with either MCMV (A and B) or LCMV (C and D).
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TABLE VI-I. Splenic MCMV Titers in Intact and Anti-aGM
- Treated
J32m /-) and C57BL/6 (+/+) Mice
Log lO PFU/s leen :I SD
Exp anti-aGM C57BU6J32m 
/-)
0:.3 3.3:1.6:. 5:1 .2
3 .3:1.3
1:0.
0:. 3.4:10.2
2:. 4. 6:1 .2
a Age-matched 
J32m /-) and C57BU6 (+/+) mice were infected with 1 x 10 PFU ofMCMV
1.p.
b Splenic MCMV was titrated on 
C57BU6 mouse embryo fibroblasts, 3 days post inection.C p values of the diferent experiments are as follows: Exp 1: J32m /-), p -: 0. , C57BL/6
, p
-: 0. 005. Exp 2: J32m /-), p -: 0. 07. Exp 3: J32m /-), p -: 0. 02; C57BU6 p -: 0.00003.d :Mce received anti-aGM
antiserum, i. , or no treatment at the time of inection.
e Not determed.
f Splenic NK cells ITom uniected, MCMV -inected and MCMV -infected, anti-aGMI-treated
mice were used as effectors agaist Y AC- I targets. The results are shown in Figures VI- I A
and VI- IB.
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/-) mice (Table VI- I). These experients therefore indicate that 2m expression on either
effector NK cells or their targets is not required for the anti-vial properties ofNK cells in vivo.
REGULATION OF MCMV BY C57BL/6 AN M (-/-) SPLEEN CELLS IN
MCMV -INECTED C57BL/6 SUCKLING MICE
To further show that the regulation of MCMV by NK cells is not dependent on
MHC class I expression, the ability of 2m (-/-) spleen cells to control MCMV synthesis 
days post-infection in C57BL/6 suckling mice was measured. Adoptively transferred P2m
/-) adult spleen cells significantly lowered MCMV titers in the suckling mice when
compared to the media control (Table VI-2). The level of protection afforded by the P2m
/-) spleen cells was similar to that of C57BL/6 adult spleen cells (Table VI-2). These
experiments indicate that despite the differences in the expression of MHC class I
molecules between the effector cell and the target cell 2m (-/-) spleen cells can stil
protect C57BL/6 suckling mice ITom MCMV.
REPLICATION OF LCMV IN NK CELL-DEPLETED P M (-/-) MICE
By a number of criteria, LCMV is considered an NK cell-resistant virus (Bukowski et
al. , 1983; Bukowski and Welsh, 1985b; Bukowski et al. , 1985), and it has been speculated that
LCMV may be resistant to NK cells because IF can upregulate class I MHC on LCMV-
inected target cells and protect these infeced targets from NK cell-mediated lysis (Brutkiewicz
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Table VI-2. Control ofMCMV by C57BL/6 and 132m (-/-) Adult Spleen cells in
MCMV-Infected C57BL/6 Suckling Mice
Exp Group LOglO PFU MCMV/spleen value
Media Control
132m (-/-) spleen cells
CS7BL/6 spleen cells
3 . O::.
2. 2::.4
2.2::.
-( O.
-( 0.
Media Control
132m (-/-) spleen cells
C57BL/6 spleen cells
7::.
1.7::.
2. O::. 2
-( 0. 005
-( O. OOS
a Four to six day old C57BL/6 suckling mice were given i.p. SOOO PFU MCMV per
mouse.
b One day prior to infection
, the suckling mice were given i.
, 0. 1 ml complete RPMI, S x
C57BL/6 spleen cells or S x 10 132m (-/-) spleen cells.C Splenic MCMV titers were measured using C57BL/6 MEF 3 days post-
infection.
value is calculated by comparing the MCMV titers of the adoptively reconstituted
group to the media control group within the same experiment.
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et al., 1992; Bukowski and Welsh, 1985b). If indee, this were the mechansm of the
resistance ofLCMV to NK cells, one might expect LCMV to be an NK-sensitive vis in the
2m (-/-) mice. In agreement with previous reports (Bukowski et al., 1983; Bukowski and
Welsh, 1985b; Bukowski et al. , 1985), C57BL/6 mice sythesized similar levels of LCMV
whether or not the mice had been NK cell-depleted (Table VI- , Exp 1). Synthesis ofLCMV
in the 2m (-/-) mice was vially identical to the levels in the C57BL/6 mice, and depletion of
NK cells had no effect on the LCMV titers in the 2m (-/-) mice (Table VI-3). These
experients therefore argue agaist the hypothesis that the upregulation of class I MHC
antigens by vis-induced IF protects LCMV -infected targets ITom the anti-viral effects of
NK cells.
EXPRESSION OF CLASS I MHC ANTIGENS IN VIUS-INECTED MICE
The possibilty existed that vial inections induced cell surface expression of class I
MHC antigens in the 2m (-/-) mice. To test for this, thymocyes ITom uniected and vis-
inected mice were examned for surface class I expression using both MHC class I
conformation-dependent and conformation-independent alo-antibodies. Figures VI-2 and VI-
3 show that MCMV and LCMV infections up-regulated the expression of class I MHC
antigens on thymocyes from virus-inected C57BL/6 mice. In contrast, no signcant
expression ofMHC class Ion thymocyes ITom the virus-inected 2m (-/-) mice was detected
with either the conformation-dependent or conformation-independent allo-antibodies. Similar
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TABLE VI-3. Splenic LCMV Titers in Intact and Anti-aGM1-Treated fhm (-/-) and
C57BL/6 (+/+) Mice
mlO PFU/s leen :1 S.
Exp anti-aGM 132m (-
/-)
C57BL/6
5:10. 5:10.
6:10. 5:10.
5.4:10.
9:10.
3:10.
1:10.
5. 1:0. 1 
1:0.
a Age-matched 
132m (-/-) and C57BL/6 (+/+) mice were infected with 5 x PFU of
LCMV i.
b Splenic LCMV was titrated on Vero cells
, 3 days post-infection.C p 
values of the different experiments are as follows: Exp 1: 132m (-/-), p .( 0.
C57BL/6 , P.( 0.7. Exp2: p.( 0.2. Exp 3: p.( 0.6. Exp 4: p': 0.d Mice received anti-aGM
antiserum, i.p. or no treatment at the time of infection.
Splenic NK cells ITom uninfected, LCMV-infected and LCMV-infected, anti-aGM
treated mice were used as effectors on Y AC- I targets. The results are shown in Figures
VI-IC and VI- ID.
Not determned.
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results not depicted were shown using the pan- class I-specific mAb, MI. This
demonstrates that the J32m (-/-) mice failed to express surface class I antigens detectable by
antibody even durig a vis infection.
CYTOTOXIC CAPACITY OF NK CELLS FROM VIUS-INECTED 
DEFICIENT MICE
Splenocyes ITom J32m (-/-) mice were tested for their cyolytic capacity agaist a
varety of targets to determe the specifcity and magntude of their lytic function. Large
cortical, cortisone-sensitive thymocyes appear to be natural targets for NK cells and can be
shown in vitro to be highy sensitive to NK cell-mediated lysis (Hansson et al., 1980).
Therefore, thymocytes, in addition to continuous cell lines, were tested as targets. Table VI-4
shows that J32m /-) splenocytes ITom LCMV -infected mice displayed only moderate levels of
cytotoxicity agaist the prototyic Y AC- I NK cell target and very little cytotoxicity against a
varety of other targets, including J32m /-) and J32m (+/+) cell lies and J32m (-/-) and C57BL/6
thymocytes. These tagets were much more sensitive to lysis by splenocytes ITom the LCMV-
inected genetically high NK cell strain, C3R. Thus, even though NK cells ITom J32m /-) mice
could mediate a normal anti-viral effect, their ability to lyse their own naturally NK cell-
sensitive tagets was very poor. It should be noted that when J32m /-) thymocytes were used
as targets for C3H mouse splenocytes, they were more sensitive than C57BL/6 thymocytes to
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NK cell mediated lysis. This confs work of others showig that cells lacking class I MHC
expression have enhanced sensitivity to NK cell-mediated lysis (Ljunggen and Kare, 1990).
INERFERON-MEDIATED PROTECTION OF DEFICIENT TARGET
CELLS FROM NK CELL-MEDIATED LYSIS
Some cell lies lacking class I MHC expression have been shown to be sensitive to NK
cells and are resistant to the protective effects ofIF (Ljunggen and Kare, 1990; Sandberg et
al. , 1994). We sought to confrm these reports and used a previously untested J32m-deficient
cell lie as a taget for IF-protection studies (Allen et al. , 1986; Waneck et al. , 1987). Table
VI-S showed that the J32m (+/+) cell line, DIR, an H- transfectant, expressed moderate to
high levels of class I MHC and were moderately sensitive to activated NK cells taken ITom the
spleens of LCMV-inected C3H mice. Afer treatment with IF-J3, DIR expressed higher
levels of class I MHC and became resistant to lysis by NK cells. In contrast, the RIE. J32m (-
/-) cell lie was highy sensitive to NK cells and expressed little detectble class I antigen. Afer
IF-J3 treatment, the J32m /-) cells remained sensitive to NK cells and failed to upregulate the
surface expression of conformationally normal class I, as detectable by antibody. This and
previous work (Sandberg et al., 1994; Bukowski and Welsh, 1986; Hansson et al., 1980),
suggest that the J32m /-) mice should be resistant to the IF-mediated protection of targets
that normaly occurs in vivo durig vis infections.
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PROTECTION OF M (-/-) THYOCYTES FROM NK CELLS BY IN VIVO
POLYI:C TREATMENT
To determe whether an IF inducer would be able to protect natural thymocye
targets ofJ32m (-/-) mice ITom NK cells, we treated mice with poly I:C, a potent in vivo IF-
inducer previously shown to upregulate class I MHC expression on thymocytes and to render
thymocyes resistant to NK cell-mediated lysis (Hansson et al. , 1980; Bukowski and Welsh,
1986). Figure VI-4A shows a representative experiment indicating that poly I:C treatment
rendered thymocyes ITom CS7BL/6 mice relatively resistant to lysis by activated NK cell
populations derived ITom the spleens of LCMV -infected C3H mice. Similar protection was
seen when CS7BL/6 splenocyes were used as effector cells, but the data ITom the C3H mice
are presented because the NK cell response in these mice is much higher than that in CS7BL/6
mice. In general J32m /-) effector cell populations lysed al thymocyte target types very poorly
(Table VI-4).
Thymocyes ITom untreated J32m /-) mice had higher sensitivity to NK cell-mediated
lysis relative to CS7BL/6 controls, and poly I:C-treatment only marginally reduced their
sensitivity to lysis. In a total of 3 experients, poly I:C-treatment resulted in a 30% :! 
(standard deviation) reduction in the proportion ofCS7BL/6 thymocyes lysed, but only a 10%
:! 7 reduction (S experients) in the killng ofJ32m (-/-) thymocyes. Using the mAb MI , there
was no increa in the MHC class I expression in the J32m /-) thymocytes afer poly I:C
123
6:1 12:1 25:1 50:1
6:1 12:1 25:1 50:1 12:1 50:1
Err RATIO
Figure VI-4. Sensitivity of thymocyes to NK cell killng. Thymocyes ITom uniected or
mock-treated C57BU6 (+/+) (D), 2m (-/-) (0) mice and ITom 3 day vis-ineced (LCMV
figure VI-4B; MCMV, figure VI-4C) or 2 day poly I:C-treated (figure VI-4A) C57BL/6
(+/+) (.), 
2m (-/-) (8) mice were harested and used as targets in a 4-h SICr relea assay.
Effecors were splenocyes taen ITom day 3 post LCMV -infected C3H/eSnJ mice.
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treatment wherea thymocytes taken ITom C57BL/6 mice treated with poly I:C displayed a
substantial increa in class I expression, as previously shown (Bukowski and Welsh, 1986).
These experients suggest that, simlar to the results with J32m /-) cells in Table VI- , natural
J32m /-) thymocye targets for NK cells are resistant to the protecive effects of IF (and
possibly other cyokies) induced by poly I:C.
SUSCEPTffILITY OF THYOCYTES FROM VIUS-INECTED MICE 
LYSIS BY ACTIVATED NK CELLS
Thymocyes ITom uniected or virus-infected C57BL/6 and J32m /-) mice were tested
for their sensitivity to activated NK cells. All thymocyte targets were relatively resistant to
LCMV- induced J32m /-) NK cells, so the data are agai presented using spleen leukocytes
ITom LCMV-ineced C3H mice as sources of NK cells. Figures VI-4B and C show
representative data indicating that inections with LCMV (Figure VI-4B) and MCMV (Figure
VI-4C) each caused thymocyte populations ITom C57BL/6 mice to become considerably more
resistant than untreated control thymocytes to lysis by NK cells. In 4 experiments, the LCMV
inecion cause a 38% :t 19 reduction in the proportion of C57BL/6 thymocytes lysed
whereas in each of 3 experients, the MCMV infection resulted in the complete resistance of
C57BL/6 thymocyes ITom NK cell-mediated lysis. Thymocyes ITom LCMV- infected J32m 
) mice were slightly more resistant than control J32m /-) thymocyes to NK cells, as in 7
experients there was a reduction in lysis of 21% :t 13 , but within an experient, this
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resistance was signcantly less than that of thymocytes ITom LCMV -infected C57BL/6 mice
(Figure VI-4B). Thymocytes ITom MCMV-inected J32m /-) mice were much more resistant
than control J32m /-) thymocyes to NK cells, as, in 3 experients, there was a reduction in
lysis of 48%:: 14, but they were stil signficantly less resistat than thymocytes ITom MCMV-
inected C57BL/6 mice, which completely resisted lysis (Figure VI-4C).
Hanson et al have shown that in thymocytes, the cortisone-sensitive CD4 CD8
thymocyte subpopulation is the most sensitive to NK cell lysis (Hansson et aI. , 1979). To
determe if the moderate reduction in sensitivity to NK cell kig afer MCMV infection was
due to a change in the thymocyte distribution, thymocytes ITom 3 day MCMV - and LCMV-
inected J32m /-) mice were stained with anti-CD4 and anti-CD8 mAbs. Thymocyte profies
ITom MCMV-ineced J32m (-/-) mice revealed that there was a loss of CD4 CD8+ cells
(Figure VI-5 B). This loss of CD4 CD8+ cells was even more severe in MCMV-infected
anti-aGMI-treated J32m /-) mice (Figure VI-5 C). However, this change in phenotype and
distribution of the thymocyte subpopulations was not apparant after LCMV infection or in
LCMV-infected, anti-aGM1-treated J32m /-) mice (Figure VI-5 E, F). These data suggest
that in MCMV-infected J32m (-/-) mice, the loss of the CD4 CD8+ thymocyte population
may be the cause of the increased resistance to NK cells when compared to uninfected
controls.
Data presented here showed that the sensitivity to NK cells by MCMV and the
resistance to NK cells by LCMV are unchanged in the J32m (-/-) mice, although detectable
cell surface class I MHC expression is not induced , and the IF protection mechanism is
.
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depressed. Using the adoptive transfer protocol , I provided evidence that adult J32m 
/-)
spleen cells can control MCMV synthesis in C57BL/6 suckling mice, despite the fact that
the effector cells and target cells have different levels of MHC class I expression. Taken
together, these results suggest that the regulation ofMCMV by NK cells is independent on the
expression ofMHC class I molecules either on the target cells or on the effector cells.
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CHAPTER VII
DISCUSSION
My observation that MCMV is controlled in the spleen by a perf orin-dependent
mechanism and in the liver by an IF- dependent mechanism is the first demonstration of
NK cells using different mechanisms to regulate viral infections in different organs. Some
recent work in viral and bacterial systems has suggested that the phenomenon of the same
effector cells using different mechanisms to control infections may also be occurrng with
other immune cells (Lucin et aI. , 1992; Kagi et aI. , 1994b; von Herrath et aI. , 1997). Kagi
et al (1 994b ) have shown that the amount of bacteria controlled by T cells in the spleens
of 5 or 8 day L. monocytogenes- infected perf orin % mice was significantly higher than in
perforin +/+ mice, but the bacterial load in the livers of both strains of mice were similar.
Their results indicated that the control of L. monocytogenes by T cells in the spleen was
perf orin-dependent but the authors did not investigate the anti-bacterial mechanisms used
by these T cells in the liver. von Herrath et al (1997) reported that within the CD8+ T
cells, low affnity LCMV -specific CTLs, and not the high affnity LCMV -specific CTLs
required IF- to clear an acute LCMV infection (it is not clear if the low affnity CTLs
produce the IF-
y). 
The need for IF- by low affnity CTLs to clear an acute LCMV
infection may be due to the fact that the high affnity CTLs were highly cytotoxic while the
low affnity eTLs were not (measured by cytotoxicity assays), In another system, the
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control of MCMV in the different organs of BALB/c mice was dependent on different
mechanisms provided by different cell types (Lucin et aI., 1992). Here, CD8+ T cells
utilzed an IF- independent mechanism to control MCMV in the peripheral organs'
(spleen and lung), but the control ofMCMV in the salivary glands was not dependent on
CD8+ T cells. It was instead dependent on IF- produced by CD4+ T cells (Lucin et aI
1992). Kagi et al and von Herrath et al only provided partial evidence that the same
effector cells may use different mechanisms to control a pathogen, and Lucin et al showed
that there may be a preferential use of one mechanism over another in the control of a
pathogen in a particular organ. The work presented in this thesis is the first definitive
study showing that at a given time point, the same effector cells can utilize different
mechanisms in different organs to effectively control an infection.
In addition to showing that NK cells may use different mechanisms to control
MCMV in the spleen and the liver, tillS report is also the first demonstration of NK cells
using perforin to control virus infections. Perf orin % mice had more virus in the spleen
compared to perf orin +/+ mice 3 days post-MCMV infection, while the liver titers in both
groups of mice remained similar. This suggests that the perforin-dependent mechanism is
of greater importance in the spleen than in the liver. Because perforin is related to the
cytotoxic function of NK cells, this may indicate that the cytotoxic function is important
for the control of MCMV in the spleen but not in the liver. Depletion of NK cells in
perforin % mice with anti-NK1.1 mAb resulted only in the increase ofliver MCMV titers
(Table 111-3). Such a result when taken in context with the above mentioned experiments
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is consistent with the regulation of MCMV in the spleen being mediated via a perf orin-
dependent mechanism, and the removal of NK cells in the perf orin mice should not
have affected the splenic titers. However, MCMV in the livers of perforin mice was
controlled by NK cells via a perf orin-independent mechanism, as the removal of NK cells
in the mice abrogated the resistance in that organ.
A perf orin-independent mechanism that NK cells use to control MCMV infection
in the liver is the production of the anti-viral cytokine IF-
y. 
During the course of my
studies, Orange et al showed that NK cells in C57BL/6 mice synthesize IFN-y and regulate
MCMV in the liver, but they did not report data with the spleen (Orange et aI. , 1995). My
results are in agreement with their work with the liver, but further showed that this
cytokine has anegligible anti-MCMV role in the spleen. Depletion of IF- in MCMV-
infected C57BL/6 mice with mAbs only resulted in increases in MCMV titers in the liver
but not in the spleen. These results together with the data obtained from the perf orin 0/0
mice strongly suggest that 3 days post-MCMV infection, NK cells utilized a perf orin-
dependent mechanism in the spleen and an IFN- dependent mechanism in the liver. IF-
may also be important for the control of viruses in the liver by T cells as Guidotti et al
have recently reported that in hepatitis B virus (HBV) transgenic mice, the regulation of
the virus antigen in the liver is carried out by CTLs via the production of IFN-y and TN-
a.. However the direct lysis of hepatocytes by the CTLs was minimal (Guidotti et aI.
1996).
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This dichotomy in the mechanisms used by NK cells in the control of MCMV was
also seen in IF- 0/0 mice made chimeric with C57BL/6 bone marrow cells. NK cell-
depleted, MCMV-infected chimeric IF- 0/0 mice had more virus in the spleen but
exhbited similar viral titers in the liver when compared to NK cell- intact IF- 0/0
mice (Table 111-5). These data not only reinforced the results obtained from mice treated
with anti-IF-y Abs, but they also strengthened our hypothesis that NK cells used
different mechanisms to control MCMV in spleen and the liver. The host cells of
IF- 0/0 mice did not have the ability to respond to IF-
y, 
and the depletion ofNK
cells ITom day 3 MCMV-infected B6 IFN- 0/0 mice increased only the splenic but not
the liver titers. These results suggest that the virus in the spleen was controlled by NK
cells via a IF- independent mechanism. It was stil possible that the increase in titers 
the spleens ofB6 IF- 0/0 mice after NK cell depletion could be explained by an IF-
y-mediated mechanism, as the spleens of these mice became repopulated by the donor
immune cells that would have the abilty to respond to IF-
y. 
However IFN- 0/0 mice
reconstituted with perforin % bone marrow cells showed no increase in splenic MCMV
titers after NK cell depletion, arguing against that interpretation. Also , spleen cells from
normal unreconstituted perforin mice should have IF- responsiveness, but after NK
cell depletion, titers of MCMV in the spleen were not enhanced (Table 111-3). It is
interesting to note that the depletion of NK cells in B6 129 chimeric mice resulted in
increases in both splenic and liver MCMV titers (Table 111-5), while depleting the NK cells
in Cmv- 129 mice only resulted in marginal increases in MCMV titers in both organs.
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This suggests that NK cell-dependent factors other than Cmv- are missing or non-
functional in the 129 strain. These factors wil include a high cytolytic capabilty of NK
cells and NK cell stimulatory cytokines such as IL- I2 that induce the production ofIF-
This report is also the first to indicate that the control of MCMV synthesis in the
liver is by NO. Treating mice with L-NM a competitive inhbitor of NOS, enhanced
MCMV titers in the liver but not in the spleen. This set of data adds further evidence that
IF- is more important in the liver, as one of the ways IF- can exert its anti-viral
actions is through the induction of NOS to produce NO. These results also support the
concept that different mechanisms are utilized to control MCMV as the inhibition of NO
production did not affect the control of MCMV synthesis in the spleen. Jacobs et al.
showed that the resistance to blood-stage malaria in the spleen but not the liver of
C57BL/6 mice is dependent on the expression of NO (Jacobs et aI. , 1995). However, in a
5 day ectromelia virus infection, control of the virus by NO in both the spleen and the liver
has been reported (Karupiah et aI. , 1993b), suggesting that, depending on the pathogen
the protection by NO may be an organ-dependent phenomenon or a general occurrence.
Contrary to our results, Heise et al have shown that in a 7 day MCMV infection of
CB 17 SCID mice IF- depletion increased MCMV titers in both the spleen and liver
(Heise and Virgin IV, 1995). The CBI7 SCID mice used in their analyses were NKI.1
and Cmv- and this might not allow for the dichotomy in mechanisms used in different
organs in the regulation ofMCMV by NK1.I Cmv- mice. It is also likely that in this
lengthier time of infection, the enhanced titers of virus in the liver would seed the spleen
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with more virus, eventually leading to higher titers in that organ. Interestingly, it was also
reported in the same paper that the depletion ofTN-a. resulted in increases in splenic but
not liver MCMV titers (Heise and Virgin IV, 1995).
Just as NK cells may use different mechanisms to control viruses in different
organs, their effcacy in certain organs may vary considerably. It is noteworthy that 
cells do not effectively control MCMV replication in the lungs after intra-nasal inoculation
of the virus, as the lungs of MCMV -infected beige mice or normal mice depleted of NK
1 ,
cells with antibodies had similar MCMV titers as did normal controls (Bukowski et aI.
1984).
This documentation of a Cmv- perf orin-dependent mechanism controllng
MCMV replication in the spleen leads to the suggestion that MCMV -infected splenocytes
may be lysed by NK cells. Surprisingly little information has been available concerning the
direct cytotoxicity of MCMV -infected targets by NK cells. An early report of MCMV-
infected fibroblasts being lysed by NK cells in overnght cytotoxicity assays could be
accounted for by the activation of the NK cells in the assays rather than by a selective lysis
ofMCMV-infected cells (Lee and Keller, 1982). Studies designed to examine the intrinsic
sensitivity of MCMV -infected fibroblasts to NK cells in short term assays that precluded
additional NK cell activation failed to find any indication of increased sensitivity of these
targets to lysis (Bukowski and Welsh, 1985b). Target cells in the spleen may be more
sensitive to NK cell-mediated lysis than target cells in the liver. Reports on the natural
targets of NK cell cytotoxicity in vivo have been limited to lymphocytes, lymphoma cells
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and cells of hematopoietic origin, and most demonstrations of selectivities in NK cell
recognition and lysis have used lymphocyte targets (Brutkiewicz and Welsh, 1995). It was
thus possible that studies on the NK cell sensitivity of MCMV -infected targets had not
used the most relevant target. Early work by Wu et al showed that, 3 days post-MCMV
infection, T and B cells isolated ITom blood constituted the major traction of cells infected
with MCMV (Wu and Ho, 1979). Data presented in Chapter III showed that spleen
leukocytes including Band T cells were infected with MCMV 3 days post-infection. Also
by 3 days post-MCMV infection, normal mice have a IOO-fold more virus in the spleen
than do SCID mice (Welsh et aI. , 1991), suggesting that lymphocytes are major targets of
MCMV infection in the spleens, and such targets may be good candidates for NK cell
killng. As lymphocytes were potential candidates for NK cell cytotoxicity, attempts were
made to see if specific killng of MCMV -infected lymphocytes by NK cells could be
observed. Routine Cr release assays could not be performed using MCMV -infected
splenocytes as targets because only a small percentage of the splenocyte population wil be
infected by MCMV at a given time. Furthermore, splenocytes are not good targets in the
cytotoxicity assays as they spontaneously apoptose ex vivo. Instead, splenocytes ITom 3
day MCMV-infected mice were mixed with poly I:C-treated NK cells or LAK cells for 4
hours, and the cells were plated in an infective center plaque assay. However, inconsistent
results were obtained using the infective center plaque assay technique and it is diffcult to
show specific killng of MCMV -infected targets. A collaboration with Dr. E. Tsuda-
Szomolanyi using a molecular approach to this question is in progress. DNA from
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MCMV -infected splenocytes incubated with normal or perf orin % NK cells is probed
with MCMV-specific DNA probes. The rationale is that if there is any specific killng of
MCMV-infected cells by NK cells, MCMV DNA would be degraded and there should be
a reduction in the signal picked up by the MCMV -specific DNA probes. A preliminary
experiment has suggested that there may be lower levels of high molecular weight MCMV
DNA from MCMV -infected splenocytes exposed to normal versus perforin % NK cells.
More experiments are needed to confirm this finding.
The lysis of a virus-infected cell requires that the NK cell bind to and be triggered
by the target cell. However, if the virus replication can be inhibited by thecytokines
produced by activated NK cells, the effector cell may not have to come in contact with the
virus-infected target. Target cells in the spleen may be good targets for NK cell
recognition and lysis, but hepatocytes, which constitute the major fraction of liver cells
infected by MCMV, may either not stimulate the NK cells appropriately or else not
respond to the lytic signals delivered by NK cells. Nevertheless, their sensitivity to NK
cell-produced factors such as IF- would render them susceptible to the anti-viral
functions ofNK cells.
This strategy has a few advantages from the viewpoint of the host. The production
of IF- in the liver would allow the anti-viral cytokine to reach a maximum number of
infected hepatocytes in the shortest amount of time, and this method of virus control may
be more effcient than a direct cytotoxic mechanism. Mentioned earlier, the regulation of
HBV in HBV-transgenic mice was carred out by IF-y and TN-a produced by HBV-
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specific CTL (Guidotti et aI. , 1996). These anti-viral cytokines selectively degraded the
HBV nucleosapsid particles and their replication genomes and destablized the viral RNA
(Guidotti et aI. , 1996). As direct lysis ofhepatocytes by the CTL was suffciently minimal
the host was spared ITom adverse immunopathological effects brought on by the
destruction of the hepatocytes. The same phenomenon may be happening here with
regards to MCMV. Rather than destroying the hepatocytes that are harboring the virus
the production ofIF-y may also be selectively destroying the virus without causing much
damage to the cells themselves.
In the above mentioned experiments, only one time point (3 days post-MCMV)
and one virus dose (2 x 10 PFU/mouse) was studied. This snapshot in time and the use of
one particular dose of the virus inoculum may not allow us to fully appreciate the potential
changes in the abilties of NK cells that may occur during the virus infection. It is highly
possible that at different time points post-infection, NK cells may utilize both perf orin- and
IF- dependent mechanisms to control MCMV in the spleen and the liver. These
changes in the mechanisms used by NK cells to control MCMV throughout the infection
could be studied by examining different time points post-MCMV infection and measuring
the virus titers in the spleens and livers of the different strains of mice used in my earlier
analyses. A potential caveat to these experiments is that NK cell activity starts to wane at
day 4 post-infection when the specific T cell response increases. This may be due to the
production of transformng growth factor (TGF- ) by T cells as NK cells are very
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sensitive to this cytokine and exposure to TGF-J3 decreases NK cell activity (Su et aI.
1991; Su et aI. , 1993).
My data on the dichotomy in the mechanisms utilized by NK cells when placed in
context with the data provided by other investigators (Guidotti et aI. , 1996; Kagi et aI.
1994b; Jacobs et aI. , 1995) provided a novel way of viewing the abilities of our immune
cells in the regulation of infections. These data strongly suggest that the immune system
can preferentially use different mechanisms in different organs to combat infectious
diseases. These studies caution us that in the use of immunotherapy to treat diseases, we
must pay attention to all the potential mechanisms utilzed by the effector cells, as well as
the target organ we are treating. For example in the treatment of chronic HBV infection of
the liver, the use of immune cells that are capable of producing anti-viral cytokines such as
IF- and TN-cx may be more beneficial to the host than the use of cells that have a
strong cytolytic potential in resolving the infection. A careful dissection of the different
abilities of our immune system in conjunction with the target organ may allow us to design
better therapies against various diseases.
Suckling mice less than 2 weeks of age can be used as a model to study the role of
NK cells in the regulation of MCMV because NK cells take about 3 weeks from birth to
reach maturity. In this model, spleen cells or culture purified LAK cells when transferred
into the suckling mice protect the mice from a lethal MCMV infection (Bukowski et aI.
1985). Depleting the transferred spleen cells with anti-aGM Abs abrogates this resistance
whereas depleting the T cell population before adoptive transfer has no effect on the
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transferred cells' abilty to protect against MCMV (Bukowski et aI. , 1985). In the adult
mouse/MCMV model, the regulation of MCMV in the spleen is Cmv- l- and perf orin-
dependent, but in suckling mice my results indicate that this innate resistance gene and
perf orin do not playa role in the regulation ofMCMV by adoptively transferred NK cells.
Unlike the adult mouse model, adoptive transfers of spleen cells or LAK cells derived
ITom Cmv- (C57BL/6) or Cmv- (129) mice significantly lowered splenic MCMV titers
in infected C57BL/6 suckling mice. Furthermore, perforin % spleen cells or LAK cells
are also able to regulate MCMV in the spleens of the suckling mice, indicating that the
regulation of MCMV by the transferred cells is perf orin-independent (Table IV - 1). The
mechanism used by the transferred cells is IF- dependent, as normal C57BL/6 spleen
cells when transferred into IF- 0/0 suckling mice failed to regulate MCMV synthesis in
the spleen. These results suggest that in the suckling mouse model the regulation of
MCMV does not follow the convention seen in adult mice. Adoptively transferred cells
unlike the NK cells in the adult mouse model, utilized a perf orin-independent IF-
dependent mechanism to control MCMV in the spleens of suckling mice.
It is not surprising that NK cells use different mechanisms to control MCMV in the
different mouse models. In the suckling mouse model, both the effector cells and the
pathogen are introduced into the peritoneal cavity while in the adult model, the effector
cells are part of the system before the virus is introduced. Furthermore in the adult model
there may be an infux of NK cells into the peritoneal cavity ITom the spleen (Table V- I),
while in the suckling mouse model, the adoptively transferred NK cells would have to
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traffck into the spleen ITom the peritoneal cavity to control the virus there. As the
adoptively transferred cells are present in the suckling mice prior to the introduction of the
virus, it is also possible that the control of MCMV may have occurred within the
peritoneal cavity, thereby blocking the migration of the virus to the spleen. Early work by
Bukowski et al have shown that culture purified Lyt2+ (CD8 ) LAK cells and a T cell
clone with NK cell-lie activity, when adoptively transferred into the suckling mice protect
the mice as effectively as culture purified NK cells (Bukowski et ai, 1985; Bukowski et aI.
1988). These non-NK cells probably also protected the suckling mice via an IF-
dependent mechanism.
Scalzo et al have shown the importance of Cmv- in the regulation ofMCMVby
NK cells in the spleen (Scalzo et aI. , 1990; Scalzo et aI., 1992). In all the experiments
performed using adult mice, the presence of the Cmv- gene is a prerequisite for the
regulation of MCMV in the spleens of C57BL/6 mice. This organ-dependent genetic
resistance parallels the function of perf orin, but the genes for Cmv- and perforin are on
different chromosomes. It is interesting to note that one of the genetic susceptibility genes
of mice to ectromelia virus has also been mapped within the NK gene complex, close to
the Cmv- locus, suggesting that Cmv- or a closely related gene/s may also regulate other
vial infections (Delano and Brownstein, 1995).
If all NK cells ITom C57BL/6 mice express Cmv- it would suggest that all the
NK cells have the abilty to utilze different mechanisms to control MCMV. Interestingly,
the Cmv- gene locus is believed to be closely linked to the Ly49 NK cell receptor family,
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raIsmg the possibility that this MCMV innate resistance gene IS an existing or yet
undefined member of the Ly49 family (Brown et aI., 1997). Another potential way NK
cells could utilize different mechanisms to control MCMV in different organs is by using
the different subsets ofNK cells to home to different organs and control MCMV synthesis
in that organ. It is possible that subsets ofNK cells that traffck to the spleen may control
MCMV in the spleen via a perf orin-dependent mechanism and other NK cell subsets that
home to the liver may utilze an IF- dependent mechanism to control the virus there.
There were fewer NK 1.1 + cells in the spleen and more NK 1.1 + cells in the
peritoneal cavity at 3 days post-MCMV infection (Table V- I). However, these changes in
NKI. I + cell numbers in the spleen and peritoneal cavity were not apparant during LCMV
infection, where splenic NK 1. 1 + cell numbers per lymphocytes did not fluctuate
between uninfected and infected mice (Table V- I). In 3 different experiments, the change
in NKI. I + cell numbers in the peritoneal cavities of LCMV -infected mice was at best
erratic (Table V- I). As intraperitoneal MCMV infection resulted in increases in both the
absolute number of PEC and also NKI. I + cells in the peritoneal cavity. These results
strongly indicate that there is traffcking ofNK cells to the sites of infection.
An examination of the different Ly49 subsets also revealed a change in the
distribution of the proportion of NK 1.1 + cells after MCMV infection. In the spleen, even
though MCMV did not cause any apparant change in the absolute number of splenocytes
(data not shown), the virus infection caused an increase in the percentage of Ly49A and
Ly49G2 NK cell subsets but a decrease in the percentage of Ly49C and Ly49D NK cell
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subsets. Interestingly, these changes in the proportion ofNK cell subsets within the spleen
are accompanied by decreases in the percentages of the Ly49A NK cell subset and
increases in the percentages of Ly49C, D and G2 NK cell subsets in the peritoneal cavity.
As there is a consistent pattern in the changes of the Ly49 subsets during MCMV infection
but not during LCMV infection, the different Ly49 NK cell subsets may play different
roles in the regulation of MCMV in vivo. This is the first demonstration that a virus
infection can infuence the different Ly49 NK cell subsets to shift in proportions between
different organs.
Despite the redistribution of the tested Ly49 NK cell subsets during MCMV
infection in vivo depletion of anyone of the 4 tested Ly49 subsets, or the adoptive
transfer of anyone of the 4 Ly49 NK cell subsets does not affect the ability of the NK
cells to control MCMV. To date, there are 8 cloned Ly49 NK cell receptors but there are
only antibodies available to 5 of the receptors. The anti-Ly49D Ab (I2A8) used in the
above in vivo depletion and adoptive transfer studies is cross-reactive with Ly49A NK cell
receptor such that the depletion of Ly49D-bearing cells will also cause the depletion of
Ly49A+ cells (Mason et aI. , 1996). Depleting cells with anti-Ly49G2 (4DII) Abs wil not
only deplete the Ly49G2+ cells but wil also inadvertently deplete some Ly49A+ NK cells
as well (Mason et aI. , 1995). This is because approximately 11 % of all NK cells express
both Ly49A and Ly49G2 NK cell receptors (Mason et aI. , 1995). However, the cross
reactivity of anti-Ly49D Ab and the co-expression of Ly49A and Ly49G2 on some NK
cells should not affect our understanding in the ability of the different Ly49 subsets, as the
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Ly49A NK cell subset only constitute about IS - 17% of all NK cells. Furthermore
depletion of the Ly49A NK cell subset or the adoptive transfer of the Ly49A+ or Ly49A-
LAK cells alone did not affect the ability of the NK cells to control MCMV in vivo.
Recently the anti-Ly49C Ab (SWSE6) used in my analyses was found to bind not
only with Ly49C but also with Ly49I NK cell receptor. Initial studies have indicated that
Ly49C+ NK cells mediate the rejection of H- parental bone marrow cells in FI (b x d)
mice (Yu et aI, 1996). However, recent antibody binding data show that a new antibody
4L033I1 binds to Ly49C+ cells in both CS7BL/6 and BALB/c mice, and amino acid
analyses have indicated that the Ly49C NK cell receptor in both strains of mice are
identical (Takei et aI. , 1997). Furthermore, Ly49C NK cell receptors interact with and are
inhbited by both H- - and H- bearing cells. These data suggest that in hybrid
resistance, it is the Ly49r+ NK cells that mediate the rejection of H- d bone marrow cells
(George et aI., 1997). Nonetheless, results from the in vivo depletion of Ly49C- and
Ly49I-bearing cells (using SWSE6, Table V-4), or the adoptive transfer of Ly49C
Ly49I+ or Ly49c-, Ly49r LAK cells (Table V-S) again strongly indicate that the absence
or the presence of a particular Ly49 NK cell subset does not affect the ability of NK cells
to control MCMV.
The Ly49D and Ly49H NK cell receptors are the only members of the Ly49
multigene family to date that do not contain the ITIM motif in its cytoplasmic tail (Mason
et aI. , 1996; Ryan and Seaman, 1997). Ly49D NK cells have been shown to have the
abilty to lyse tumor cells and Con A blasts of different H-2 haplotypes, and mediate
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reverse ADCC through anti-Ly49D Ab on FcyR+ target cells (Mason et aI. , 1996). These
data strongly suggest that Ly49D is a putative activatory receptor, not unlike NKl.I , and
therefore may have an important role in the regulation ofMCMV. However depleting the
Ly49D+ NK cell subset or transferring Ly49D- NK 1. 1 + LAK cells into MCMV -infected
suckling mice did not affect the NK cells ' ability to control MCMV (Table V- , Table V-
5). Taken together, the Ly49 NK cell receptor data provide strong evidence that the none
of the 4 Ly49 NK receptors are essential in the regulation ofMCMV.
For the suckling mouse model to be useful in testing the importance of Ly49 NK
cell receptors in the regulation of MCMV, the NK cells have to come in contact with the
target cells. This process is crucial, or the suckling mouse model cannot be used to study
the interactions of cell surface molecules and their importance in the control of MCMV.
Indeed there is a report that NK cell recognition of targets is a necessary factor
contributing to cytokine release (i.e. the release ofIFN-y) (Bellone et aI. , 1993). However
if cytokines like IL-I2 and TN-a alone can stimulate NK cells to produce anti-viral
cytokines (Orange and Biron, 1996a; Orange and Biron, 1996b), this may preclude the
need for NK cells to come in contact with the target cell. If the latter case is true, the
suckling mouse model wil not be useful in the study of cell to cell interactions and the
potential roles they may play in the control ofMCMV.
The evidence presented in chapter V strongly suggest that Cmv- is probably not
one of the tested Ly49 NK cell receptors. However, this evidence does not rule out the
possibilty that Cmv. may be one of the undefined Ly49 receptors, If Cmv- is one of the
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Ly49 family, it could be either an inhibitory receptor like Ly49A, C or G2 , or an activatory
receptor like Ly49D. Let' s for a moment consider Cmv- as an inhibitory receptor. The
inhbitory receptor Cmv- upon ligation with its ligand wil send a negative signal to the
NK cell, preventing the NK cell ITom killng its target. If Cmv- is an inhibitory receptor
this receptor has to be found in the BALB/c strain as BALB/c mice are MCMV-sensitive
(Scalzo et aI. , 1990). The MCMV-resistant strain C57BL/6 wil either possess a different
allelic form of Cmv- that does not recognize the ligand or does not express Cmv- at all.
One potential ligand for such an inhibitory receptor is the viral MHC class I homologue of
MCMV. This viral class I homologue has been implicated to inhibit NK cell function
(Farell et aI. , 1997), and if Cmv- is an inhibitory receptor, BALB/c Cmv- may interact
with this viral homologue and shut down the NK cell' s ability to control the virus. On the
other hand, if Cmv- is an activatory receptor like Ly49D or NKI , the yet identified
Cmv- gene product may be a receptor molecule associated with the cytotoxic function of
NK cells. It is possible that Cmv- might encode a receptor that recognizes MCMV-
infected cells or even MCMV itself Such an activatory NK cell receptor has to be found
in the C57BL/6 strain but absent or exist in a different allelic form in BALB/c mice. The
cloning and identification of the Cmv- gene product will permit us to dissect this mystery.
The interaions between MHC class I molecules and NK cell receptors dictates the
functions of the NK cells. This coupled with the fact that some viruses can induce changes in
class I molecules has alowed investigators to hypothesize that NK cells may be able to
selecively lyse vis-inected targets (Bukowski et aI., 1985; Bukowski and Welsh, 1985b;
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Storkus and Dawson, 1991; Brutkiewicz et al. , 1992; Welsh and Vargas-Cortes, 1992). Virs-
induced modulation ofMHC class I molecules could be due to a direct virus-induced inbition
in MHC gene transcrption, translation, or post-translational processing, or it could be a
conseuence of vises interfering with the actions of regulatory cytokines. IF, which induces
the upregulation ofMHC antigens, protects targets ITom NK cell-mediated lysis, and much of
this protecion correlates with the abilty ofIF to upregulate class I MHC antigens (Trinchieri
and Santoli, 1978; Welsh et al. , 1981; Ljunggen and Kare, 1990; Ljunggren et al., 1990).
Cells lackig normal class I MHC expression as a consequence of a 2m deficiency canot be
proteced by IF, but protection can be restored by transfection with an intact 2m gene
(Ljunggen and Kare, 1990; Ljunggen et al. , 1990). It has been proposed that a selective
protecion of normal but not vis-infected cells would allow NK cells in the host to selectively
lyse vis-ineced cells and control vial infections without any requirement for specific
recgntion of vis-inected targets (Trinchieri and Santoli, 1978; Santoli and Koprowski
1979). This origial hypothesis, which was based on early work showing that human fibroblasts
ineced with cert vises could not be protected against NK cells by IF (Trichieri and
Santoli, 1978), received substantial support by a varety of studies in the mouse with MCMV
and LCMV (Bukowski et al., 1983; Bukowski et al., 1985; Bukowski and Welsh, 1985a;
Bukowski and Welsh, 1985b; Bukowski and Welsh, 1986). These studies established that vial
inections induced marked elevations of class I MHC antigens in vivo (Bukowski and Welsh,
1986), and that cells (thymocyes) isolated ITom virus-infected mice resisted lysis by NK cells
as they became more susceptible to lysis by CTL (Hansson et al. , 1980; Bukowski and Welsh,
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1986). MCMV and LCMV were shown to be NK cell-sensitive and -resistant vises
respecively, in vivo but a selective killng of MCMV -infeced cells in vitro could not be
shown (Bukowski et al., 1983; Bukowski and Welsh, 1985a; Bukowski and Welsh, 1985b;
Bukowski and Welsh, 1986). IF, however, proteced LCMV- but not MCMV-inected
fibroblass ITom lysis by activated NK cells in vitro (Bukowski and Welsh, 1985b), a result
consistent with the origial hypothesis (Trinchieri and Santoli, 1978; Santoli and Koprowski
1979).
The results in Chapter VI challenge the hypothesis, as the anti-viral functions of NK
cells in the J32m /-) mice were simlar to those in normal mice. Thus, normal expression of
class I molecules per se on either the target cell or the NK cell, is not required for the anti-vial
properties ofNK cells. The data do not address the question of whether a virus infection must
down-regulate class I MHC expression in order to be sensitive to NK cells, because the class I
expression is aleay down-regulated. These results do, however, argue against the concept
that a selecive IF-induced protection ofuninfected cells via the upregulation ofMHC class I
molecules focuses the NK cell response onto virus-inected targets which resist IF-mediated
protecion. The hypothesis that LCMV is an NK-resistant virus because IF-induced
upregulation of class I MHC antigens protects them ITom NK cells is also contradicted by the
data. These results also chalenge the hypothesis that IF-protection of uninfected cells via the
upregulation of class I MHC prevents serious auto-destructive tissue injury during infection.
Splenocye or thymocye numbers in LCMV -infected J32m (-/-) mice were not altered by NK
cell depletion, indicating that NK cells were not lysing significant numbers of these leukocytes
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durig inecion (Figure VI-S). The cytotoxic capacity of the vis-induced 132m (-/-) NK cells
was relatively wea agaist any target other than Y AC- I cells, and this may have precluded a
signcant self-destructive response. Alternatively, by being educated in a 132m (-
/-)
envionment, the 132m (-/-) NK cells may have a recogntion system distinct ITom 132m (+/+) 
cells and may detec subtle differences in the low levels of cell surface MHC class I expression
on 132m (-/-) cells (Hoglund et aI. , 1991).
NK cells ITom 132m (+/+) mice made chimeric with 132m (-/-) bone marrow cells did
not kill 132m (-/-) Con A blasts, suggesting that the education of NK cells by cells of
hematopoietic origin dictates the functions of the mature NK cells (Hoglund et aI., 1991).
Even though NK cells ITom 132m (-/-) mice do not kill 132m (-/-) Con A blasts, these cells
are able to lyse TAP-deficient RMA-S cells more effciently than the parental RMA cells
(Hoglund et aI. , 1997). In fact, 132m (-/-) NK cells can distinguish between EL- 132m (-
cells (these cells express 20 - 40% ofMHC class I molecules compared to the wildtype)
and EL- 132m (+/+) by lysing the former (Hoglund et aI., 1997). The education of NK
cells can be explained by using the Receptor Calibration Model (Sentman et aI., 1995;
Hoglund et aI. , 1997). The model makes the assumption that NK cells once triggered by
activating receptor/ligand interactions require a certain amount of inhibitory interactions to
occur, which wil lead to the turning off of the lytic program and release of the effector
cells ITom the target. This model depends on at least 3 factors: a. the concentration of the
receptors on the NK cell surface, b. the concentration of MHC class I molecules on the
target cell surface and c. the affnity of the interactions between the receptors and MHC
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class I molecules. Studies on the Ly49 NK cell receptors have indicated that 132m (-/-) NK
cells have a higher percentage of Ly49A, C and G2 receptors than C57BL/6 mice
(Dorfan Jr. et aI. , 1996 Salcedo et aI. , 1997). These data suggest that the higher levels
ofNK cell receptors in 132m (-/-) mice is to be able to recognize the lower levels ofMHC
class I molecules. Therefore, 132m (-/-) NK cells can kill EL- 132m (-/-) cells but not 132m (-
/-) con A blasts, because the latter have higher levels of MHC class I molecules.
Alternatively, there may be no calibration of the NK cell receptors, because the class I
levels in 132m (-/-) mice are too low to affect the NK cells. If this is the case, 132m (-/-) NK
cells do not kill 132m (-/-) Con A blasts because there may be fewer activatory ligands on
the cells. These two possibilties can be tested by using NK cells and target cells from
TAP-/132m (-/-) (undetectable class I molecules), 132m (-/-) (barely detectable class I) and
T AP- (detectable class I albeit at 90% reduction compared to the wildtype) mice to test if
NK cells are calibrated according to the amount of class I molecules found within the
education compartment.
132m (-/-) adult spleen cells when adoptively transferred into C57BL/6 suckling
mice did protect the suckling mice from MCMV, suggesting that the education of NK
cells was not essential in the control ofMCMV. However the same concerns voiced in the
section where the suckling mouse model was used to study Ly49 NK cell receptors apply
in this analysis too. Until better experimental approaches are developed, or the question of
whether cell to cell contact is necessary for the production of anti-viral cytokines by NK
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cells is clarfied, the issue of NK cell education in the control of MCMV wil remain
unresolved.
Thymocyes isolated ITom poly I:C-treated Jhm (-/-) mice were considerably more
sensitive to NK cells than were thymocyes ITom treated CS7BL/6 mice, a result consistent
with the hypothesis that IF-mediated protection in vivo was dependent on expression of
MHC class I antigens (Figure VI-4). Thymocytes isolated ITom virus-infected P2m (-/-) mice
were, however, somewhat more resistant to lysis than those ITom poly I:C-treated mice, even
though they did not upregulate MHC class I antigens (Table VI-4). We do not know the
explanation for this resistance, but it could involve changes in thymocyte distribution occurrng
as a consequence of vial infection. The thymocyte number in MCMV-infected CS7BL/6 and
P2m (-/-) mice was markedly reduced, and there was a severe depletion in the CD4 CD8
subset (Figure VI- , Brutkiewicz, 1993). In anti-aGMdreated, MCMV-infected P2m (-
/-)
mice, there was a further loss of the CD4 CDS+ subset (Figure VI-S). We believe that this
severe loss in the double positive thymocye population was not due to the cytotoxic capacity
of the NK cells but was instead due to the increased replication of the virus afer NK cell-
depletion. Furthermore, glucocorticoids produced by the host during vis infections may
eliate the cortisone-sensitive CD4 CD8+ thymocyte population, and this thymocyte
subpopulation is shown to be most sensitive to NK cell lysis (Hansson et aI., 1979).
Inection of mice with the NK cell-resistant LCMV did not afect the phenotype or thymocyte
number (Figure VI-S). This may be due to the differences in cytopathicity between the 2
vises; MCMV being higWy cytopathic while LCMV is not. Nonetheless, it remains possible
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that some protection of the target cells in vivo was due to mechansms other than IF-
mediated upregulation of class I MHC antigens (Routes, 1992). Thus, although MCMV is a
highy sensitive vis to NK cells in vivo fibroblast tagets inected with MCMV in vitro 
not show enance sensitivity to NK cell-mediated lysis (Bukowski and Welsh, 1985b), and
the data preseted here are inconsistent with the concept of a selective funneling of NK cells
toward tissues not expressing class I MHC.
Other than MHC class I molecules, there undoubtedly are many NK cellligands that
remain undefined and could playa role in NK cell interactions with virus-infected targets.
An earlier study with human NK cell clones showed that some clones lysed varicella-
zoster vis-, HCMV - or VV -infected targets while others did not, suggesting the
possibility of some NK subset selectivity in recognizing virus-infected targets (Mason et
aI., 1993). Recent studies using cloned human NK cells have shown similar selectivity
against human herpes virus 6 (H-6)-infected cells (Malnati et aI. , 1993), but the ability
of the NK clones to lyse these infected cells was thought not to depend on MHC class I
expression, as there was little difference in class I levels between HH - infected and the
uninfected cells (Malnati et aI., 1993). These results suggest that other cell surface
elements can restrict NK cell recognition. The rat NK-PI can bind oligosaccharide
ligands (this has yet to be confirmed by other investigators) and the mouse NK receptor
Ly49A is a C-type lectin that has a functional carbohydrate recognition domain (Bezouska
et aI. , 1994; Daniels et aI., 1994). NK cell receptors may therefore recognize the
carbohydrate or sugar motifs on the class I molecules or even on other proteins.
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Substantial earlier work had indicated that purified glycoproteins ITom mumps, measles
infuenza, and other viruses can augment the cytolytic activity of NK cells in vitro and 
vivo (Harfast et al. , 1980; Casali et aI. , 1981; Arora et aI. , 1984; Arora and Houde, 1988);
it is not known whether these glycoproteins or their sugar moieties interact with the
defined NK receptor molecules.
Cell surface molecules other than MHC class I may act as NK cell-triggering
molecules. Costimulatory molecules expressed on the target cells may activate NK cells to
lyse the target. NK cells have long been implicated in the outgrowth of B cells transformed
by EBV, and EBV has recently been shown to upregulate the costimulatory molecule
CD80 (B7-I) on infected cells (Montel et aI., 1995). In fact this upregulation of B7-
molecules on EBV-infected cells enhanced their susceptibility to lysis by a human NK
variant cell line that expresses CD28 (Montel et aI., 1995). Recently, co stimulatory
molecules were shown to play an important role in the regulation of parasitic infections 
SCID mice. Infection of SCID mice with T. gondii resulted in the expression of CD28 on
NK cells, accompanied by the production ofIF-y by the NK cells and increase in NK cell
cytolytic activity. In vivo administration of CTLA4-Ig, which blocks the interaction
between CD28 and B7 into T. gondii- infected SCID mice, resulted in a significant increase
in parasitic load, demonstrating the importance of this co stimulation through B7 in
resistance to T. gondii (Hunter et aI., 1997). Another recent article also suggests that
mouse NK cells can be activated by B7- 1 (Chambers et aI. , 1996), but this activation is
reported not to occur through B7- I/CD28 or B7- l/CTLA-4 interactions, implicating a
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third receptor for B7- 1. Interestingly, in this article the presence ofMHC class I molecules
on the target cells does not inhbit their susceptibility to NK cell killng as long as the
targets express B7- 1. These results suggest that B1- 1 expressed on virus-infected cells
may trigger the NK cells to lyse the virus-infected targets, and that the expression of class
I molecules is inconsequential to the outcome.
The results described in this thesis have given us a better understanding about the
mechanisms utilized by NK cells and the roles played by NK cell receptors and MHC class
I molecules in the regulation of MCMV. Listed below are the important observations
made in this thesis:
1. In the early regulation of MCMV infections in adult C57BL/6 mice, NK cells utilized
different mechanisms to control the virus in the spleen and the liver. In the spleen, a
perf orin-dependent mechanism was used, while an IF- dependent NO-mediated
mechanism was used in the liver. This dichotomy in the mechanisms used by NK cells
to control MCMV was dependent on the expression of the Cmv- gene found within
the NK gene complex of the mouse.
2. Unlike the regulation of MCMV infection in adult C57BL/6 mice, adoptively
transferred NK cells control MCMV in the spleens of suckling mice via an IF-
dependent mechanism.
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3. There is a redistribution of NK cell subsets between the spleen and the peritoneal
cavity 3 days post-MCMV infection. Per 10 lymphocytes, there is an increase in the
percentage ofLy49A+ and Ly49G2+ NK cell subsets and a decrease in the percentage
of Ly49C+ and Ly49D+ NK cell subsets in the spleen. This is accompanied by a
decrease in percentage of Ly49A+ NK cell subset and increases in the percentages of
Ly49C+, Ly49D+ and Ly49G2+ NK cell subsets in the peritoneal cavity.
4. Despite the change in the distribution pattern of the Ly49 receptors 3 days after
MCMV inection, NK cells in C57BL/6 mice retain the ability to control MCMV in
the absence ofLy49A-, Ly49C-, Ly49D- or Ly49G2-bearing NK cells.
5. Normal expression of MHC class I molecules on NK cells or their targets is not
required for the anti-viral functions ofNK cells against a NK-sensitive virus (MCMV)
nor do they protect a NK-resistant virus (LCMV) from the anti-viral activity of NK
cells.
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